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The reprogramming of enzyme catalytic activity and selectivity is a central issue 
in protein biochemistry and biotechnology.  Numerous structure-guided and directed 
evolution strategies have been employed in search of enzyme variants that exhibit high 
catalytic rates with poor or inactive substrates of the parental enzyme.  As impressive as 
these successes have been, the engineering of enzymes that exhibit turnover rates and 
selectivities with new substrates comparable to their natural counterparts has proven quite 
a challenge, especially when considering those enzymes for which a genetic selection 
strategy is not possible.  
By utilizing bacterial display and multi-parameter flow cytometry we have 
developed a novel methodology for emulating positive and negative selective pressure in 
vitro for the isolation of enzyme variants with reactivity for desired novel substrates, 
while simultaneously excluding those with reactivity towards undesired substrates.   
 vii
In order to demonstrate the application of the high-throughput flow-cytometric for 
protease engineering; we sought to evolve a set of highly active OmpT variants that have 
P1 specificities altered systematically to recognize one amino-acid from each of the six 
classes of amino acids   By screening error-prone and multiple residue saturation libraries 
we describe the systematic directed evolution of a set of proteases with altered 
recognition sites.   A set of OmpT variants were engineered that can specifically cleave 
substrates having a hydrophobic, polar, aromatic and even acidic residue at the P1 and 
Arg at the P1’.    In particular we note that the change in electrostatic specificity from a 
basic amino acid (Arg) to an acidic (Glu) is unprecedented.   
After successfully changing P1 specificity, we then focused our attention on 
isolating OmpT mutants that recognize altered P1’ specificities such as Ala and Val.  
Towards this end, we show the isolation of highly active OmpT variants that cleave Arg-
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Enzyme engineering: Altering the substrate 
specificity of enzymes 
 
1.1 Introduction  
Enzymes are intricate biocatalysts whose specificity has been shaped by evolution in the 
context of their physiological substrates. These remarkable molecular machines have a 
tremendous advantage over traditional chemical catalysts not only because of high 
chemo- and stereoselectivity coupled with high rate accelerations. Advances in 
recombinant technology have made modification and production of enzymes relevant on 
the industrial biocatalysis scale (1),(2). One of the major obstacles in the application of 
enzymes as widespread catalysts is their specificity towards physiological substrates 
rather than industrially relevant ones. Enzyme engineering, either through rational design 
or combinatorial screening, can identify enzyme variants with modified properties like 
enhanced stability in organic solvents (3). One of the intriguing aspects of enzymes is 
their catalytic promiscuity, providing enzyme engineers an avenue to reprogram 
specificity (4). The ability to modify the specificity of enzymes can serve two functions; 
improving properties important for practical catalysis, while the other is increasing the 
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understanding of their mechanism and evolution from both a molecular and biological 
standpoint. For example, alteration of substrate specificity has been used to understand 
the evolution and mechanism of the E. coli chaperone GroEL/S (5), understand the 
evolution of microbial resistance to antibiotics (6), and discern accessible pathways in 
Darwinian evolution (7).  
In the following sections, the enzymes have been classified by super-family according to 
the amount of research dedicated towards altering their substrate selectivity and/or 
mechanistic/substrate similarities. Wherever appropriate, the application of directed 
evolution towards understanding biological mechanisms has been highlighted. 
 
1.2 Rational design of biocatalysts 
Although the de novo design of biocatalysts is still an extremely challenging problem (8), 
there has been recent progress. For instance, Park et al. describe the design and evolution 
of new catalytic activity with an existing protein scaffold. The authors used SAIFE 
(simultaneous incorporation and adjustment of functional elements) that consists of 
insertions, deletions, and substitution of gene elements in conjunction with directed 
evolution to select for β-lacatamase activity in the structurally homologous glyoxalase II 
αβ/βα metallohydrolase (Figure 1.1) (9). Dwyer et al. on the other hand used structure-
based computational design techniques that led to new catalytic activites in binding 
proteins (10). Using their methodology they were able to design a glycolytic enzyme 
analogous to triose phosphate isomerase based on the ribose-binding protein. Ueno et al. 
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demonstrated the design of metal cofactors activated by a protein-protein electron 
transfer system (11).  Heme oxygenase catalyzes the conversion of heme to biliverdin, 
utilizing the electrons provided from a NADPH/cytochrome P450 reductase system (CPR). 
By designing a Fe(III) (Schiff-base) heme oxygenase as the electron acceptor, they were 
able to design a synthetic metal complex activated by a protein-protein electron transfer 
relay system (For a review on the rational design of heme enzymes please see (12)). Wei 
et al. used binary patterning of polar and non-polar residues (for a recent review please 
see (13)) to generate combinatorial de novo protein libraries.  In order to test the 
feasibility of de novo designed folded proteins to yield catalytic enzymes, they tested the 
esterase activity of S-284, a four-helix bundle protein. S-284 displayed a 8700-fold rate 
enhancement for the hydrolysis of p-nitrophenyl esters over the uncatalyzed reaction 





















































































































































































































































































































































































































































































































 1.3 Rational redesign of substrate specificity. 
The computational redesign of enzyme substrate specificity has been demonstrated for 
enzymes with well-characterized function and structures. Computational algorithms have 
been used not only to modify enzyme function but also to remodel protein-protein 
interfaces (16). Ashworth et al. have used a physically realistic atomic-level force field 
algorithm to redesign the cleavage specificity of the intron-encoded homing endonuclease 
I-MsoI (17). By using an in silico screen to disrupt the affinity of the protein towards the 
wild-type recognition sequence 5’ -GCAGAACGTCGTGAGACAGTTCCG-3’ and re-
optimizing the amino acid cluster around the target recognition site 5’ 
CAGAAGGTCGTGAGACCGTTCCG 3’ they designed and characterized a modified 
protein I-MsoI DES that had both lower experimental affinity and higher cleavage 
specificity for the target sequence. The experimental verification of the design algorithm 
highlighted its efficiency in the context of other engineered restriction endonucleases 
identified using directed evolution (discussed below) and has demonstrated the 
application of such algorithms as viable avenues for the re-design of substrate selectivity 
for enzymes with well-characterized structures. 
The ability to commit a promiscuous enzyme to recognize/catalyze a specific substrate(s) 
has been demonstrated for at least two different enzyme systems. γ-Humulene synthase is 
a promiscuous sesquiterpene synthase that catalyzes the conversion of a single substrate, 
farnesyl diphosphate, to 52 different sesquiterpenes. Yoshikuni et al. identified residues 
that constitute the active-site contour and performed single-site saturation mutagenesis at 
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these sites and recombined them using a computational algorithm to yield a set of six γ-
humulene synthases tailored to yield different terpenes (18). Again, Calmodulin (CaM) is 
a promiscuous enzyme that has evolved to bind to 14-30 amino acid stretches on a variety 
of target proteins. In order to tailor CaM to be specific for a smooth muscle myosin light 
chain kinase peptide (smMLCK, Figure 1.2), Shifman et al. selected for residues that 
simultaneously increased the affinity of the enzyme towards smMLCK, while decreasing 
the affinity towards alternative targets (19). Using an optimization algorithm that ensured 
preservation of fitness with the desired peptide while simultaneously exploring tolerated 
residues that decreased the affinity towards alternate targets, they designed a CaM variant 








Figure 1.2: “(A) X-ray structure of CaM in complex with smMLCK (PDB code 1CDM) 
generated with MOLMOL. Ca2+ atoms are shown as yellow spheres. The CaM surface 
and boundary residues selected for optimization are shown in red. The core residues in 
the CaM-binding interface, shown in cyan, and the smMLCK residues, shown in light 
yellow, were allowed to change conformation during the optimization procedure.(B) 
Fitness of CaM interacting with the desired target, smMLCK (red), and with alternative 
targets (blue). The CaMwt sequence lies near the respective maxima for both the desired 
target and the alternative targets as indicated by *. Arrows show the change in fitness due 
to mutations in the CaM sequence predicted by the optimization.” Figure and caption 
reproduced from Shifman, JM Mayo, SL Proc. Natl. Acad. Sci (2003), 100, 13274. 





1.4 Directed evolution 
Although rational re-design of protein substrate specificity is a powerful tool for enzymes 
with well characterized structures and substrates, the method of choice to generate novel 
enzymes with altered functions remains directed evolution. The advantage of using 
directed evolution is that it is a combinatorial approach to screen for the relevant 
phenotypic function. The use of directed evolution to evolve modified proteins 
necessitates the use of either a genetic selection to select for survival or a screen/assay to 
scan libraries. Basically, directed evolution (Figure 1.3) involves three steps; first the 
candidate enzyme(s) to be evolved is identified; second, a combinatorial library of 
enzyme mutant genes is generated and third a screen/selection of enzyme activity is 
employed to pick out winners. Additional rounds of mutagenesis/screening can be 
performed until the enzyme variant has the desired new functional activity. A recent 
review on directed evolution summarizes most of the current methodologies to generate 
diversity at the genetic level (20) including but not limited to, error-prone PCR (ePCR), 
DNA shuffling, incremental truncation for the creation of hybrid enzymes (ITCHY) and 






















Figure 1.3: Directed evolution scheme. Two different mutagenesis strategies are shown; 
error-prone PCR indicated by colored stars on a single gene framework; and 
recombination obtained by crossing-over one or more genes.  
 
1.4.1 Restriction endonucleases/recombinases. 
Restriction endonucleases are the backbone of recombinant DNA technology and genome 
engineering (21). Restriction enzymes represent a particularly stringent model system for 
altering enzyme substrate specificity since any engineered enzyme must recognize the 
requisite target DNA sequence in the context of a wide variety of other sequences 
including the DNA sequence recognized by the starting parent(s). Plus, there are detailed 
structures of restriction endonucleases complexed with cognate as well as non-cognate 
substrates (22). Arnould et al. use a semi-rational approach to alter the DNA specificity 
of I-CreI, a homing endonuclease of the LAGLIDGAG family (23). First, they 
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constructed a lacZ reporter plasmid in which the lacZ gene is interrupted with an insert 
containing the site of interest flanked by two direct repeats. Next, a strain harboring the 
expression vector encoding the endonuclease library was mated with the strain containing 
the interrupted lacZ reporter (Figure 1.4).  Upon mating, active endonucleases restore 
functional lacZ by performing double stranded breaks at the sites of interest. Four 
variants that had altered specificity were extensively characterized in vitro and displayed 
half-maximal reaction kinetics comparable to the wild-type (WT) parent. Additionally, 
since the LAGLIDGAG family of endonucleases normally function as homodimers, 
variants that cleaved new DNA targets can be assembled by creating heterodimers. 
Although cleavage at sequences recognized by either homodimers still occurred, the 
authors showed that hybrid DNA sequences could now be recognized.  
Working with the same LAGLIDADG family of endonucleases, Chevalier et al. used a 
combination of computational redesign and an in vivo folding screen to generate 
heterodimeric chimeras of I-DmoI and I-CreI (24). The best enzyme, E-DreI16, has eight 
computationally designed point mutants at the domain interface and recognizes a hybrid 
DNA sequence not recognized by either parent, but shows no cross-reactivity to the wild-




Figure 1.4: “The yeast mating assay for the selection of modified I-CreI variants.” Figure 
and caption reprinted from Arnould et al. (2006) J. Mol. Biol, 355, 433. Copyright © 
2006, with permission from Elsevier. 
 
Samuleson et al. use a dual genetic selection protocol to isolate NotI mutants that 
recognize the alternate DNA sequence 5’ GCTGCCGC 3’ (25). In step 1, an SOS 
induction assay was employed by using a DNA-damage indicator strain ER1992 
harboring a pACYC-eagIM plasmid to pre-modify and protect all 5’ CGGCCG 3’ sites 
within the genome. Endonuclease cleavage at all sites other than 5’ NCGGCCGN 3’ 
would induce the SOS response leading to a lacZ readout. By screening a randomly 
mutated notIR gene library, they isolated the E156K mutant that cleaved at 5’ 
GCTGCCGC 3’. In order to further improve the activity of the variant, a second selection 
was performed wherein highly active mutants would eliminate a vector harboring a toxic 
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protein tox-yidC. The best mutant, M91V/E156K, was able to cleave seven alternate sites 
with nearly the same efficiency as the cognate NotI site, indicating a relaxation in the 
specificity of the enzyme. 
BsoBI is a thermophilic restriction endonuclease that recognizes the DNA sequence 5’ 
CPyCGPuG 3’and cleaves after the first cytosine. According to the structure of the 
BsoBI-DNA co-crystal, the Asp246 of BsoBI makes a water-mediated hydrogen bond to 
N6 of the degenerate base adenine. Zhu et al. used saturation mutagenesis at Asp246 to 
look for BsoBI variants with altered DNA cleavage specificity (26). The Asp246Ala 
mutant had a 70-fold greater affinity for the 5’ CCCGGG 3’ DNA sequence. Using an 
SOS induction assay, they screened for revertants that cleaved the wild-type (WT) 
preferred sequence 5’ CTCGAG 3’ and found that most of the mutations that restored 
WT-like activity were located outside the DNA-protein interface. 
Two different groups have independently designed a similar selection scheme for altering 
the specificity of the restriction endonuclease I-SceI by modulating survival of cells 
harboring the “control of cell death B” (CcdB) protein (27, 28). By incorporating a 
simultaneous negative selection to weed out non-specific mutants, Doyon et al. report the 
isolation of 2-4, an I-SceI variant that showed comparable in vivo activity to the WT I-
SceI enzyme (28). 
FokI, a type IIS restriction enzyme, is a broad non-specific DNA cleaving enzyme. The 
C2H2 zinc finger is a common DNA binding motif. Engineered zinc fingers (29) with 
novel specificities can be coupled to the cleavage domain of FokI to generate zinc-finger 
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nucleases (30). Urnov et al. have employed a GFP-based flow-cytometric gene correction 
assay to engineer zinc-finger nucleases designed against the X-linked severe combined 
immune deficiency (SCID) in the IL2Rg gene (31).  
Site-specific recombination of DNA (32) is catalyzed by recombinases that perform three 
essential functions; recognition of the target sites, cleavage, and rejoining. The Cre 
recombinase from bacteriophage P1 recognizes a 34bp double stranded DNA sequence 
called loxP. Two independent reports demonstrate the engineering of the Cre 
recombinase to recognize alternate DNA sequences. Buchholz et al. used a 
recombination based PCR strategy to identify mutant Cre recombinases that cleaved an 
alternate DNA seuence termed loxH (33). In order to eliminate non-specific mutants that 
recognized both loxH and loxP, they performed an additional selection to eliminate cross-
reactivity. The most specific recombinase mutant, Fre22, showed selectivity for loxH 
over the WT loxP sequence, as determined by both in vivo and in vitro experiments. 
Santoro et al. used a fluorescence-activated cell sorting (FACS) based approach for 
identifying Cre mutants that selectively recognize unnatural recombination sites (34).  
They used a two plasmid system, one containing a Cre recombinase contact residues 
library and the other containing two fluorescent proteins GFPuv and EYFP. Cells 
containing an active recombinase would rearrange the reporter plasmid leading to GFP 
and EYFP fluorescence that are monitored in independent channels of a flow-cytometer. 
By performing additional rounds of negative selection where recombination is based on 
 13
the natural loxP sites, they isolated Cre(+-)#4 that showed selectivites and in vitro 
recombination frequencies comparable to that of the WT protein. 
One of the paradigms of directed evolution is, “ you get what you screen for”. Wherever 
enzyme specificity is a strict requirement and cross-reactivity does not lead to a desirable 
enzyme, as illustrated with restriction enzyme engineering above, the incorporation of 
simultaneous negative selections facilitates the isolation of specific enzyme variants. 
 
1.4.2 Engineering enzyme substrate specificity for organic synthesis 
The enantioelective synthesis of organic compounds/pharmaceuticals is a billion dollar 
industry constantly requiring the use of steroselective and efficient catalysts (2, 35). 
Enzymes are ideally suited for this purpose not only because they are extremely efficient 
catalysts but also because most of them are steroselective. Unfortunately, the use of 
enzymes is limited by their narrow substrate selectivity and lack of activity in organic 
solvents. A substantial amount of research has then been focused on altering the 
specificities of natural enzymes to tune them to commercial substrates and towards 
increasing their activities in organic solvents. Gupta et al. have recently reviewed the use 
of enzymes in organic solvents and their engineering in low water content media (3). In 
the following section, a few notable examples of enzymes engineered for organic 
synthesis are presented. 
Cytochromes P450 constitute a superfamily of enzymes capable of catalyzing a diverse 
array of organic transformations. One of the most challenging problems in organic 
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chemistry is the activation of the relatively strong C-H bond. Dioxygen-supported alkane 
hydroxylation can be achieved though the use engineered cytochrome P450s (36, 37). 
Although the preferred substrates of cytochrome P450 BM3 are medium chain fatty acids 
(C12-C18), Peters et al. have engineered P450 BM-3 variants that can catalyze the 
oxidation of very small alkanes like methane and ethane to the corresponding alcohols 
(38). Interestingly, two of the isolated variants were found to be highly regioselective and 
eneantioselective towards small chain alkanes (C7/C8).  
Urlacher et al. have summarized the applications of microbial P450s in biotechnology (39, 
40). Other efforts towards bio-hydroxylation though substrate engineering are highlighted 
in a recent review by Raadt & Griengl (41). 
Aldolases are enzymes that catalyze enantioselective C-C bond forming reactions. 
Despite their widespread potential, narrow substrate specificity limits their use in 
industrial scale processes. Sialic acid aldolase catalyzes the condensation of N-acetyl-D-
manosamine and pyruvate to yield N-acetyl-D-neuraminic acid (sialic acid). Hsu et al. 
engineered the Sialic acid aldolase to invert the stereochemistry of the substrate sugar 
(Figure 1.5) to accept L-3-deoxy-manno2-octulosonic acid (L-KDO) (42). By coupling 
the aldol cleavage reaction to the reduction of pyruvate to lactate and the concomitant 
oxidation of NADH to NAD+ by lactic dehydrogenase, they assayed for aldolase variants 
by monitoring NADH fluorescence. After five rounds of screening, they isolated aldolase 
mutant N5B2 that showed a completely different sugar specificity profile, with L-KDO 




Figure 1.5: “Directed evolution of D sialic acid aldolase to L-KDO aldolase.” Figure and 
caption reproduced from Hsu et al. Proc. Natl. Acad. Sci. (2005), 102, 9122. Copyright © 
2005 by the National Academy of Sciences. 
 
An orthogonal approach to engineer aldolases is to alter the stereochemical course of the 
bond-forming step, enabling the formation of a completely different diastereomer from 
the same starting materials. Fructose-1,6-biphosphate aldolase (FBPA) catalyzes the 
formation of fructose-1,6-biphosphate starting with dihydroxyacetone phosphate (DHAP) 
and glyceraldehydes-3-phosphate (G3P). Williams et al. used a DNA shuffling (43) 
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based approach to isolate mutants of the D-tagatose-1,6-bisphospate (TBPA) that could 
catalyze the formation of the FBP (44). The best variant, 3-23B5, had only four mutations 
relative to TBPA, but still showed a ~70 fold improvement in activity towards FBP. 
The different classes of aldolases and their substrate preferences have been summarized 
in a recent review by Samland & Sprenger (45). Franke et al. have highlighted the recent 
directed evolution efforts towards aldolase variants (46). 
 
Figure 1.6: Stereochemistry of the reaction catalyzed by aldolases. (A) The mechanism 
of TBP aldolase. The DHAP ene-diolate is formed after abstraction of the 1-proS proton 
from DHAP and polarization by the catalytic zinc cation. Attack of the activated DHAP 
C1 from its Si face onto the G3P C1 Re face generates the 3S, 4S product tagatose 1,6-
bisphosphate, and proton donation by H-B (Asp-82) converts the C4 carbonyl to a 
hydroxyl group, completing TBP synthesis. (B) The mechanism of FBP aldolase. The 
DHAP ene-diolate is formed after abstraction of the 1-proS proton from DHAP by Glu-
182 and polarization by the catalytic zinc. Attack of the activated DHAP C1 from its Si 
face onto the G3P C1 Si face and proton donation by H-B (Asp-109) convert the C4 
carbonyl to a hydroxyl group, completing the synthesis of the 3S,4R product fructose 1,6-
bisphosphate. FBP and TBP are epimeric at C4, and this position is marked with an 
asterisk. R = CH(OH)CH2OPO32-. Figure and caption reproduced from Williams et al. 
Proc. Natl. Acad. Sci. USA (2003) 100, 3143. Copyright © 2003 by the National 
Academy of Sciences. 
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Asymmetric catalysis is one of the foremost challenges in organic synthesis. Using 
directed evolution to modify the enantioselectivity of enzymes, a variety of 
transformations have now been performed to yield enantiopure products (47).  Natural 
product glycosides such as calicheamicin, doxorubicin, vancomycin and nystatin have 
therapeutic applications. The chemoenzymatic synthesis of such glycoconjugates often 
depends on the availability of the corresponding sugar-1-phosphates. Starting with the E. 
coli galactokinase GalK that recognizes D-galactose, Hoffmeister et al. used a high-
throughput multi-sugar colorimetric screen to isolate a GalK mutant Y371H that 
displayed a substantial degree of kinase activity towards L-sugars like L-glucose and L-
altrose (48). Surprisingly, the Y371H mutant could still phosphorylate D-galactose 
efficiently, making it an anomeric D/L sugar kinase.  
Reetz et al. used a medium-throughput GC based screening system to derive 
enatioselective variants of cyclohexanone monooxygenase (CHMO) as catalysts in the 
Baeyer-Villiger oxidation of 4-hydroxycyclohexanone (49). Although the WT enzyme 
favored the formation of R-lactone with an enantiomeric excess (ee) of just 9%, the best 
variant, 1-H7-F4, favored the formation of the R lactone with an ee of 54%. Another 
variant, 1-K2-F5, identified in the same screen favored the formation of the S lactone 
with an ee of 79%. CHMO enzyme variants were thus evolved that were specific for the 
formation of either enantiomer. The same group also reported the evolution of CHMO 
variants that catalyze the air oxidation of thioesters to yield either the R or the S 
enantiomer with >95% ee (50). 
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The application of high-throughput assays for the directed evolution of lipases and 
esterases has recently been reviewed by Schmidt & Bornscheuer (51). 
A completely different methodology for the creation of enzymes that catalyze organic 
transformations is the engineering of artificial metalloenzymes. The methodology 
involves grafting of coenzyme analogs or catalytic metal co-factors onto the active site of 
protein scaffolds either using site-specific, covalent anchoring (52), or supramolecular 
anchoring (53).  A recent review by Thomas & Ward succinctly summarizes the field 
(54). 
 
1.4.3 Acylases/ Proteases 
Proteases and acylases are enzymes that catalyze the hydrolytic cleavage of amide bonds. 
Proteases/peptidases cleave the amide bonds in proteins/peptides and are involved in the 
degradation and activation of proteins. Acylases on the other hand hydrolyze amide 
bonds other than those found in peptides.  
Semi-synthetic cephalosporins are an important class of commercial antibiotics. 7-
aminocephalosporanic acid (7-ACA) and 7-aminodesacetoxycephalosporanic acid (7-
ADCA) are important intermediates in chemoenzymatic synthesis of cephalosporins. Sio 
et al. performed site-saturation mutagenesis at residue Phe375 to investigate the ability of 
the Pseudomonas SY-77 gluataryl acylase to perform enzymatic deacylation of adipyl-7-
ADCA to yield 7-ADCA (55). Although the kcat for the SY-77Phe375Cys variant with 7-
ADCA was the same as wild-type, the KM decreased by about 6-fold to yield an overall 
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6-fold more efficient enzyme. Not surprisingly, almost all of the variants had a preference 
for the WT substrate gluataryl-7-ACA. The same group had earlier published a paper on 
the directed evolution of β-subunit of the cephalosporin acylase to alter the substrate 
specificity towards 7-ADCA (56). Using 7-adipyl leucine as the sole leucine source on 
minimal plates, they isolated variants that were 8-fold better than the starting parent in 
catalyzing the deacylation reaction. Sio & Quax have also reviewed the industrial 
applications of β-lactam acylases (57). 
In an interesting application of the directed evolution of substrate specificity, Weinreich 
et al. showed that Darwinian evolution of cefotaxime resistance in the TEM family of β-
lactamases could follow very few mutational pathways (7). In an earlier study, Orencia et 
al. had applied directed evolution to predict the emergence of antibiotic resistance (6). 
Working with a hypermutator strain of E. coli they evolved cefotaxime resistance based 
on a survival selection and showed that the in vitro engineered variant 







Figure 1.7: The crystal structure of the TEM-52 clinical isolate (PDB ID: 1HTZ). The 
active site residues are shown in black. 
 
Proteases are ubiquitous proteins that play a key role in a wide range of physiological 
processes like protein degradation, signaling, apoptosis, regulation and activation. 
Consequently, a plethora of proteases exist with varying specificities and activities. One 
of the most well known examples of protease substrate engineering is the conversion of 
trypsin into chymotrypsin. Although both proteins are serine proteases and share 
considerable structural homology, chymotrypsin cleaves after large hydrophobic residues 
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while tryspin cleaves after basic residues. Converting trypsin into a chymotrypsin like 
protease, however, required the modification of entire surface loops 185-188 and 221-225 
(58). 
Alkaline proteases have long generated industrial interest because of their application as 
detergent additives. Gupta et al. have summarized the optimization and applications of 
bacterial alkaline proteases for industrial applications (59) and Maurer has reviewed 
detergent proteases (60).  
Subtilisins are a family of alkaline serine proteases secreted by a wide variety of Bacillus 
species. Subtilisins (Figure 1.8) represent one of the most well studied, characterized and 
engineered enzymes owing to their large-scale industrial applications as detergent 
additives and skin and leather processing enzymes. The enzyme has no disulfide bonds 
and consists of a single polypeptide chain of about 275 residues. Subtilisin is synthesized 
as the apo-enzyme (a characteristic feature of proteases), secreted across the cytoplasmic 
membrane and matured into the final active form by cleavage of the pro-sequence by 
autocatalysis. The pro-sequence is believed to mediate the folding of the final mature 
form of subtilisin (61). Upon completion of folding the pro-sequence is then auto-






Figure 1.8: The crystal structures of (A) subtilisin BPN (PDB ID: 1GNS) and (B) 
autoprocessed Ser221Cys-subtilisin E-propeptide complex (PDB ID: 1SCJ) 
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The human immunodeficiency virus type I protease (HIV PR) catalyzes the cleavage of 
nine divergent amino acid sequences within the HIV-1 Gag-Pol, thereby enabling the 
activation of proteins essential for viral replication. The conformation and shape of the 
polypeptide being cleaved as opposed to consensus amino acid sequences dictates 
recognition. It is essentially a non-specific protease and is cytotoxic when expressed in 
either mammalian or E. coli cells. By using a high-throughput β-gal inactivation assay 
O’Loughlin et al. selected for HIV PR mutants that were non-toxic to the E. coli cells in 
which they were expressed (64). One variant, P9S/I150L, exhibited improved specificity 
for TNF-α/βGAL, the selection substrate. In addition, the double mutant showed reduced 
cytotoxicity when expressed in E. coli cells. Western blotting and in vitro analysis using a 
synthetic HIV-1 peptide confirmed the specificity inversion.  
The E. coli outer membrane endopeptidase OmpT is a member of the omptin family of β-
barrel proteins. The enzyme has a strong preference for cleavage at dibasic residues (65). 
Olsen et al. from our group used a fluorescence-activated cell sorting (FACS) based 
screen in order to isolate OmpT variants (Figure 1.9) (66). The selection peptide was a 
FRET peptide with a positively charged tail that was used to anchor the fluorescent 
moiety upon proteolysis onto the negatively charged E. coli outer surface. By screening 
an error-prone library OmpT variants were isolated that cleaved an Arg-Val sequence. 
The best variant, C5, showed a 60-fold improvement in catalytic efficiency for cleavage 
of an Arg-Val sequence compared to OmpT.  
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The two papers highlighted above are rare examples of protease screening in vivo. 
Traditionally, high-throughput protease screening in vivo has been challenging due to two 
main obstacles, cytotoxicity, and auto-proteolysis. The isolation of highly active soluble 
protease variants in vivo seems unlikely, mainly to due to the degradation of essential 
proteins. Similarly, highly active proteases have a tendency to cleave themselves leading 
to loss of function. Interestingly, many proteases in nature, including chymotrypsin and 
trypsin, use this auto-proteolytic function to achieve the opposite effect. These proteases 












Figure 1.9: Flow-cytometric assay used for the screening of OmpT libraries expressed on 
the surface of E. coli. 
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D-amino-peptidase (DAP) and the R61 D,D-carboxypeptidase are members of the large 
family of penicillin-recognizing, active site serine enzymes. D-aminopeptidase catalyzes 
the hydrolysis of N-terminal D-Ala residues while the R61 D,D-carboxypeptidase (R61) 
catalyzes the hydrolysis of D-Ala from peptide fragments containing two C-terminal D-
Ala residues. The DAP enzyme is comprised of three distinct domains A, B &C. The 
backbone of the DAP-A domain harbors the active site and is structurally homologous to 
the R61 enzyme. By using a combination of homology structure guided site-directed 
mutagenesis and γ-loop deletion, Delmarcelle et al. engineered a mutant DAP-A domain 
(DAP-475G-487-N275R) that when complemented with B&C domains showed 
carboxypeptidase activity in vitro (67).  
Domain recombination allows for assembly of structurally independent functional 
domains. In proteins where the catalytic site and association/folding are well separated, 
domain recombination can generate new functions. Factor Xa protease and trypsin belong 
to the S1 serine protease family whose two homologous β-barrel subdomains assemble to 
form the binding sites and catalytic machinery. Hopfner et al. engineered a factor Xa 
(fXa)/trypsin chimera by combining the N-terminal β-barrel of fXa with the C-terminal β-
barrel of trypsin (68). The hybrid protein, rfXYa, showed a substrate specificity profile 






Transferases are enzymes that catalyze the transfer of functional groups from a donor 
molecule to an acceptor molecule. The important classes of enzymes from a directed 
evolution standpoint in the transferase family are glycosylases, transaminases 
(aminotransferases) and glutathione transferases. 
Glutathione-S-transferases (GSTs) are essential components of the cellular detoxification 
machinery and eliminate reactive electrophilic compounds by conjugating them to the 
Glutathione (GSH) tripeptide. The theta class GSTs posses a C-terminal alpha helical 
extension that contains both the electrophile and GSH binding sites in addition to the 
highly conserved GST fold. Griswold et al. used a combination of homology-dependent 
and homology-independent methodologies for generating chimeric GSTs starting with 
the rat GSTT2-2 (rGSTT2-2) and the human GSTt-1-1 (hGSTT1-1) (69). They screened 
the chimeric GST library using a high-throughput flow-cytometric assay for isolating 
variants that had high levels of rGSTT2-2 like activity (Figure 1.10). One of the isolated 
clones, SCR23, substituted two H-site helices from rGSTT2-2 into the hGSTT1-1 
framework and had a catalytic efficiency that was 3.5 times better than the rGSTT2-2 and 
300 times better than the hGSTT1-1. Additionally, SCR23 conjugated GSH to ethacrynic 
acid, a reaction disfavored by both starting parental enzymes. The ability to shuffle 
enzymes with low sequence homology demonstrated in the preceeding example should 
help accelerate the discovery of humanized enzymes with low immunogenicity. The same 
group has also reported the directed evolution of rGSTT2-2 like activity starting with 
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hGSTT1-1 by using a combination of error-prone PCR and DNA shuffling (70).  The 
best variant, HEPShEP-aa7, showed a 20,000-fold increase in activity compared to the 
starting parent, hGSTT1-1, for the conjugation of CMAC to GSH. Interestingly, 
construction of a three-residue saturation library (the residues were identified based on 
other screening experiments) and subsequent flow-cytometric screening led to the 
isolation of S3-7, an enzyme with ~4000-fold increase in reactivity with CMAC. 
Emren et al. constructed chimeric GST libraries by shuffling the cDNA encoding the 
human GSTM1-1 (M1) and GSTM2-2 (M2) genes (71). A set of 384 random clones from 
the library and the two parental enzymes were expressed individually in E. coli. The 
multi-dimensional catalytic activities were analyzed using a set of eight different 
substrates. Using principal component analysis (PCA) to analyze this multidimensional 
space they identified two enzyme variants, 342 &383, that had substrate reactivity 









Figure 1.10: “Gene and protein structures of GSTT enzymes. (A) Schematic 
representation of selected chimeric genes. Sequences inherited from hGSTT1-1 are 
shown as red bars, and segments from rGSTT2-2 are shown as blue bars. Insertions not 
derived from either parent are represented as green bars. Positioning of the progeny 
segments corresponds to their origin in the parental genes (depicted at top). Point 
mutations are represented as white (silent) or green (encoding for amino acid 
substitution) stars. Sequences encoding the G and H sites are noted. (B) Mapping of 
SCR9 amino acid sequence onto the crystal structure of the hGSTT2 monomer. Human-
derived sequence is in red, rat sequence is in blue, and identical amino acids at fusion 
points are in magenta. The location of the active site is marked with a black star. (C) 
Mapping of SCR23 amino acid sequence onto the hGSTT2 structure. Point mutations are 
shown in green.” Figure and caption reproduced from Griswold et al. Proc. Natl. Acad. 
Sci. USA (2005), 102, 10082. Copyright (c) 2005 by the National Academy of Sciences. 
 29
Aminotransferases are essential metabolic enzymes that catalyze the transfer of an amino 
group between amino acids and 2-oxo acids. The aspartate 2-oxoglutarate 
aminotransferase (AspAT) from E. coli displays a marked preference for acidic substrates 
and shows almost no activity with β-branched amino acids like valine. Yano et al. used a 
selection system based on growth of auxotrophic E. coli complemented with AspAT 
libraries to evolve AspATs that catalyze the transamination of 2-oxovaline (72). They 
first knocked out the branched-chain amino acid aminotransferase gene, ilvE from E. coli. 
An ilvE deficient strain cannot grow on minimal plates without being supplemented with 
valine, leucine and isoleucine. Next, they transformed an AspAT shuffled library into the 
knockout strain so that AspAT mutants that showed high efficiency towards β-branched 
amino acids could complement the ilvE knockout and lead to survival on minimal plates. 
Using this selection scheme, they isolated a mutant AspAT enzyme, AV5A-7, that 
catalyzed the transamination of 2-oxovaline 105 times better than the starting parent 
enzyme. To date, this represents one of largest increases in activity towards a non-natural 
substrate for an engineered enzyme. 
In a series of papers, the Kirsch group has reported the directed evolution of the E. coli 
aspartate aminotransferase (eeAATase) towards converting it into the homologous 
tyrosine aminotransferase (eeTATase).  Using homology modeling, they first constructed 
HEX by introducing substitutions rationally based on the active site of eeTATase (73). 
Although the activity of HEX towards phenylalanine increased by more than three orders 
of magnitude, the enzyme still preferred aspartate. Starting with HEX as a template, they 
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made a library of HEX mutants using DNA shuffling and selected for variants that 
complemented tyrosine auxotrophy (74). This led to the construction of the HEX+ 
Ala293Asp variant that preferred tyrosine to asparate, by a factor of six. A third 
eeTATase variant, SRHEPT, constructed by combination of selection and rational 
mutagenesis, showed an activity and specificity profile similar to HEX (75). A 
particularly interesting aspect of the research is the comparison between the in vitro 
evolved enzyme and its natural counterparts. By incorporating the Ala293Asp mutation 
into SRHEPT, Chow et al. further increased the Phe/Asp specificity of the enzyme 
variant (76). 
Glycosyltransferases are enzymes that catalyze the transfer of activated monosaccharides 
onto a wide variety of acceptor substrates. These enzymes catalyze the synthesis of all 
carbohydrates. Recently, two different approaches have been reported for the directed 
evolution of glycosyltransferases. Aharoni et al. have developed a flow-cytometric assay 
for the engineering of sialyl transferases (77). They used a two-plasmid system, one 
carrying the CMP-Neu5Ac synthetase gene to activate Neu5Ac (sialic acid) and the other 
plasmid encoding the CstII sialyl transferase library. Cells expressing active CstII 
variants that could conjugate sialic acid to BODIPY lactose (fluorescent acceptor sugar) 
would thus be fluorescent, allowing isolation via a fluorescence activated cell sorter 
(FACS). Using this strategy, they isolated CstIIPhe91Tyr, a mutant that showed a 153-
fold improvement in catalytic efficiency relative to the WT enzyme in utilizing BODIPY-
lactose as the acceptor sugar. In addition, the CstIIPhe91Tyr variant could also utilize 
 31
BODIPY-3SH-lactose as an acceptor, a sugar not recognized by the WT enzyme. Love et 
al. describe a phage display (For a review of phage display for the directed evolution of 
enzymes please see (78)) based assay for the evolution of glycosyltransferases (79). They 
used a phagemid to express the E. coli glycosyltransferase (MurG) as a fusion to pIII. and 
The phage-bound MurG to catalyze the transfer of 14C-labeled UDP-GlcNac onto a 
biotinylated lipid which was captured on a streptavidin coated membrane. Scintillation 
counting was used to quantitate the formation of the lipid conjugate. 
Glycosidases have the opposite effect of glycosyltransferases; they catalyze the 
hydrolysis of glycoside bonds. Feng et al. describe the engineering of β-glycosidase of 
Thermus thermophilus towards increasing its ability to catalyze the transglycosylation 
reaction (80). They constructed an error-prone library of the β-glycosidase (β-Gly) 
enzyme and used a negative screen to identify mutants that displayed low levels of 
hydrolytic activity. Working with this smaller subset of variants, they selected for 
enzymes that showed a high transglycosylation activity to yield enzymes with favorable 
transglcysoylation/hydrolysis ratios. The best enzyme, Phe140Ser, could effect 
regiospecific transglycosylation while simultaneously suppressing glycolysis. Given the 
difficulties in oligosaccharide synthesis and the challenges associated with 
glycosyltransferase substrate engineering, directed evolution of soluble glycosidases 
appears a viable alternative towards assembling these sugars. 
There are numerous examples of the engineering of substrate specificity of glycosidases 
towards hydrolysis of alternate sugars. Highlighted below, is one such example. A recent 
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review by Hancock et al. summarizes the engineering of glycosidases and 
glycosyltransferases (81).  
Beta-glucuronidase catalyzes the hydrolytic conversion of β-D-glucuronoside to D-
glucuronate. Since the E. coli beta-galactosidase (lacZ) and the beta-glucoronidase 
(gusA) probably diverged from a common ancestor, Mastsumura & Ellington engineered 
a gusA enzyme variant that could catalyze the hydrolysis of β-galactoside (82). Using the 
standard X-gal plate assay, they isolated a quadruple mutant Thr509Ser/ Ser557Pro/ 
Asn566Ser/ Lys568Gln that cleaved a β-galactosidase substrate 500 times more 
efficiently than the wild-type enzyme. Additionally, the gusA mutant preferred the pNP-
galactoside substrate to the pNP-glucoronide substrate. 
 
1.4.5 Bioremediation enzymes 
One of our key weapons in the fight against organic/toxic pollution is bioremediation 
using either whole microbial organisms or their enzymes. As a byproduct of 
environmental contamination, bacteria and other microorganisms have evolved to use 
these pollutants/contaminants as a source of nutrients in a remarkable illustration of 
evolution/adaptation. The ability to engineer enzyme substrate specificity of these 
bioremediation enzymes enables the detoxification of a wider array of contaminants. 
Organophosphate pesticides like parathion and chlorpyrifos and chemical warfare nerve 
agents like soman and cycolosarin are extremely toxic by virtue of their irreversible 
inhibition of acetylcholinesterase. The human serum paraoxonase (PON1) is primarily a 
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lactonase but is also capable of hydrolyzing organophospates like paraxon. PON1s are 
enzymes with broad substrate specificity and are expressed poorly in E. coli. Aharaoni et 
al. used DNA family shuffling based solubility engineering (83) to increase the 
recombinant expression of the PON1s in E. coli (84). Three rounds of shuffling followed 
by screening lead to the isolation of variant G3C9 that could be expressed at 12 mg/l in E. 
coli. Since the G3C9 expression variant, like its parent PON1, demonstrated greater 
catalytic efficiency towards hydrolysis of phenylacetate than organophosphates, the 
authors constructed a random mutagenic library of G3C9 variants to select for enzymes 
that preferred a coumaphos like the fluorogenic substrate DEPCyC. Screening resulted in 
the isolation of two new enzymes, G3C9.10 and G3C9.49 that showed a preference for 
DEPCyC hydrolysis compared to phenylacetate hydrolysis. They also used family 
shuffling to increase the rate of hydrolysis of paraoxon 240-fold in the homologous 
enzyme PON3.  
1,2,3-trichloropropane (TCP), a member of the family of chlorinated hydrocarbons, is a 
toxic water pollutant. Chlorinated hydrocarbons are widely used a solvents in organic 
synthesis. Haloalkane dehalogenases are α/β-hydrolases that catalyze the conversion of 
haloalkanes to the corresponding alcohols. The haloalkane dehalogenase (DhaA) from 
Rhodococcus is an enzyme with a broad specificity. Since the byproduct of the 
dehalogenase reaction is the corresponding hydrohalide, Bosma et al. used a plate-
screening assay based on the pH indicator eosin-methylene blue (EMB) (85). A 10,000 
member randomly shuffled library was screened for the development of red color after 
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exposure to TCP vapor. After two rounds of screening they isolated a DhaA variant M2 
that showed ~8-fold improvement in hydrolyzing TCP. In order to test the feasibility of 
the evolved mutant in eliminating TCP, the M2 variant was introduced into the 2,3-
dichloro-1-propanol utilizing bacterium Agrobacterium radiobacter. Indeed, this 
engineered strain could now metabolize TCP and the pH of the culture increased as result 
of the production of hydrochloric acid. Janssen has recently summarized the efforts 
towards the evolution of haloalkane dehalogenases as bioremediation enzymes (86). 
Nitroaromatics are a class of versatile organics and have a wide range of applications 
from explosives to dyes. Unfortunately, 4-nitrophenol (4NP) and 3-methyl-4-nitrophenol 
(3M4NP) are also common industrial pollutants that pose environmental and health risks. 
4-Methyl-5-nitrocatechol (4M5NC) oxygenase (encoded by the dntB gene) isolated from 
Burkholderia is an FAD dependent enzyme that can catalyze the NADPH assisted 
oxidation of 4M5NC to 2-hydroxy-5-methylquinone. Leungsakul et al. constructed error-
prone libraries of the 4M5NC oxygenase to screen for variants capable of oxidizing 4NP 
and 3M4NP (87). The entire library was screened on plates using the nylon membrane 
agar colony-screening method. The 4M5NC variant Met22Leu/Leu380Ile was identified 
after overnight incubation at 37C on 4NP plates.  This variant showed a 4-10 fold higher 
rate of nitrite release during the oxidation of 4NP and 3M4NP relative to the WT enzyme. 
Also, the variant had ~11-fold increase in catalytic activity towards 4NP oxidation. In 
addition, site saturation mutagenesis at residues 22 and 380 indicated the synergistic 
nature of the Leu22 and Ile380 mutations. 
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Another pollutant, s-triazine, can be hydrolyzed by two distinct enzymes AtzA and TriA 
by dechlorination and deamination respectively. Although these two enzymes have little 
substrate overlap and catalyze different bond hydrolysis they differ by only nine amino 
acids. Raillard et al. used DNA shuffling to create a 1600 member library of chimeric 
enzymes and screened them against a synthetic library of 15 triazines using mass 
spectrometry (88). A panel of chimeric enzymes was isolated that recognized substrates 
from the synthetic library not recognized by either parental enzyme. 
Alcade et al. have developed colorimetric assays for the laccases catalyzed 
biodegradation of polycyclic hydrocarbons (89). Laccases are fungal enzymes that can 
facilitate the oxidation of phenolic compounds to the corresponding quinones. In order to 
monitor the oxidation of anthracene by laccases to 9,10-anthraquinone, they reduced the 
9,10-anthraquinone to 9,10-anthrahydroquinone (Abs. Max. 419nm, ε = 4000 M-1cm-1) 
using a water-soluble solution of sodium borohydride. The activity of laccase towards 
anthracene could thus be monitored spectrophotometrically.  
Alcalde et al. have reviewed the evolution and application of bioremediation enzymes 
(90). 
 
1.4.6 Isomerases & Ligases 
Isomerases catalyze the inter-conversion of isomers. This class of enzymes includes 
racemases, epimerases, mutases and cis-trans isomerases. Ligases are enzymes that 
catalyze the coupling of two molecules using a high-energy phosphate source like ATP. 
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This class of enzymes includes the acyl-CoA ligases that catalyze the formation of a C-S 
bond, synthases like peptide synthase that aid C-N bond formation, carboxylases that 
catalyze C-C bond joining, DNA & RNA ligases that ligate nucleic acids, chelatases that 
catalyze the reaction between metals and tetrapyrroles and lastly aminoacyl-tRNA 
synthetases that are essential for protein synthesis. From a directed evolution standpoint, 
most effort has been directed towards altering the specificity of aminoacyl tRNA 
synthetases to incorporate non-natural amino acids. 
 
N’-[(5’-(Phosphoribosyl)formimino]-5aminomimidazole-4-carboxamide ribonucleotide 
(ProFAR) isomerase (HisA) and phosphoribosylanthranilate (PRA) isomerase are a pair 
of similar enzymes that are believed to have evolved from a common ancestral enzyme 
and are involved in the biosynthesis of histidine and tryptophan respectively. These are 
enzymes of the (βα)8 barrel structural family, and since they catalyze similar reactions, 
Jurgens et al. used directed evolution to evolve TrpF like activity in the HisA parent (91). 
A library of mutants was constructed using DNA shuffling on the Thermotoga maritime 
HisA (tHisA) gene. The plasmid library was then transformed into an E. coli dtrpF strain 
(JMB9) and tHisA variants that could complement tryptophan auxotrophy were selected. 
Selection yielded three colonies, two of which where identical. In vitro steady state 
kinetic characterization of the two enzyme variants revealed that both enzymes behaved 
as extremely poor catalysts in the HisA isomerization reaction. Further, the tHisA_2 
mutant showed appreciable kinetics with the TrpF reaction and although the catalytic 
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efficiency of the evolved enzyme was still about 4 orders of magnitude lower than the 
WT tTrpF, it was deemed primarily a KM effect. 
 On the same concept of the patchwork hypothesis (divergent evolution) of enzyme 
evolution (92), Poelarends et al. have studied the evolution of enzymic activity in the 
tautomerase superfamily (93). Since 4-oxolocrotonate tautomerase (4-OT) and trans-3-
chloroacrylic acid dehalogenase (CaaD) are members of the same tautomerase family but 
catalyze completely different reaction chemistries, they mutated the two active-site 
residues in 4-OT to the corresponding amino acids in CaaD. The double mutant 
Leu8Arg/Ile52Glu showed a ~32-fold improvement in catalytic efficiency for the 
catalysis of the dehalogenation reaction. 
Alanine racemases are bacterial enzymes that catalyze the interconversion of L & D 
alanine. Pyridoxal 5’-phospate (PLP) is an essential cofactor for a wide array of enzymic 
reactions like aldol condensations, transaminations and racemizations. The alanine 
racemase (Alr) from Geobacillus stearothermophilus is a PLP dependent enzyme. The L-
threonine aldolase from Thermatoga maritime is an evolutionarily unrelated PLP 
dependent enzyme. Although the two enzymes have completely different reaction 
chemistries and act on different substrates, the first step in the mechanism of both 
enzymes is the formation of aldimine intermediates between PLP and their respective 
substrates. Seebeck and Hilvert have taken advantage of this common link to engineer 
aldolase activity into Alr (94). Since the Tyr265 of Alr is the base that catalyzes the 
deprotonation step during racemization, replacement of this tyrosine with alanine served 
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two functions. First, since the Tyr265 is essential for racemization activity, the 265Ala 
mutant had a much lower racemase activity. Second, the Tyr265Ala substitution 
decreased sterics and increased the volume of the binding pocket to allow for binding β-
Phenylserine and initiate the reaction with PLP to form the aldimine. The AlrTyr265Ala 
variant showed a 2.3 x 105 fold increase in aldolase activity and a 4x103 fold decrease in 
racemase activity; a remarkable change in reaction preference based on a single point 
mutation.  
A series of papers from the Hilvert group describes the evolution of chorismate mutase 
for the optimization of activity (95, 96)and re-engineering the enzyme topology (97, 98). 
In WT E. coli strains, DsbA and DsbC are primarily responsible for disulfide bond 
formation in the periplasm. Although, these structurally homologous proteins contain a 
CXXC thioredoxin (Trx) active-site motif they catalyze complimentary functions, DsbA 
functions as an oxidase and DsbC functions as an isomerase. Segatori et al. engineered a 
set of DsbC-DsbA and a DsbC-TrxA chimeric proteins that are capable of catalyzing 
both protein oxidation and disulfide isomerization in the periplasm (99). The engineered 
chimeras could complement both Dsbc activity, as measured by a tPA refolding assay, 
and DsbA activity, as confirmed using alkaline phosphatase and cell motility assays.  
Since the cell motility is critically dependent on the oxidation state of the periplasm, 
Masip et al. have engineered a disulfide bond formation pathway independent of the 
DsbA-DsbB catalytic system by using motility assays (100). By constructing a double-
site saturation library of the central XX residues in the CXXC TrxA motif, they isolated 
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variants that could complement DsbA-DsbB knockouts in restoring cell motility. 
Interestingly, the TrxA(CACC) and TrxA(CACA) variants behaved like ferredoxin type 
proteins by associating with [2Fe-2S] clusters (Figure 1.11). The ease of conversion of a 
reductase into an oxidase, based on just two mutations, indicates the adaptability of these 
essential proteins.  
 
Figure 1.11: “Physiological and engineered disulfide bond formation pathways in the E. 
coli periplasm. (A) In the physiological pathway, DsbB provides oxidizing equivalents to 
DsbA, which acts as a general catalyst of protein thiol oxidation. e–, electrons; Q, 
quinones; cyt ox, cytochrome oxidases. (B) Pathway for the formation of disulfide bonds 
by ssTorA-TrxA(CACC). Assembly of the [2Fe-2S] cluster occurs in strains with 
oxidizing cytoplasm (trxB or trxB gor AhpC* mutants), and the dimeric form of the 
protein is subsequently exported through the Tat translocator. B1: Catalysis by dimeric 
TrxA(CACC) with the [2Fe-2S] center intact. B2: Catalysis by a two-part system in 
which the TrxA(CACC) dimer dissociates in the periplasm to release free iron and 
thioredoxin. Stoichiometric transfer of a disulfide from the cytoplasm may also be 
occurring (not shown).” Figure and caption from Masip et al. Science (2004), 303, 1185. 
Reprinted with permission from AAAS. 
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Aminoacyl-tRNA-synthetases are enzymes responsible for charging (ligating) the tRNA 
with its cognate amino acid. Given the evolutionary constraints on the responsibility of 
these enzymes to ensure the fidelity of cellular protein synthesis it would seem likely that 
these enzymes would have extremely narrow substrate specificities. Although non-
discriminating tRNA-synthetases have been identified and characterized (101), by and 
large, these are highly specific enzymes in the context of their natural substrates. The 
substrate-binding pocket of aminoacyl-tRNA-synthetases, however, has been shown to be 
surprisingly plastic (102) with respect to directed evolution of new substrate specifcities 
and protein engineers have taken advantage of this plasticity to incorporate an extensive 
array of amino acids into recombinant proteins. 
Link et al. have reported a general flow-cytometric assay to screen for variants of the E. 
coli methionyl-tRNA-synthetase (MetRS) that can selectively incorporate reactive amino 
acids (103). A methionine auxotroph, M15MA, was transformed with a multiple-residue 
saturation library of the MetRS and the cells grown in minimal medium with the 19 
natural amino acids and azidonorleucine (ANL). Simultaneously, OmpC expression was 
induced by the addition of IPTG. To select for cells expressing ANL incorporated 
recombinant OmpC, they were tagged sequentially with biotin-PEO-cyclooctene and 
fluorescent avidin (Figure 1.12). Fluorescent cells were then sorted using a flow-
cytometer. Analysis of three of the variants isolated indicated that the Leu13Gly change 
was essential to create more room in the binding pocket of the MetRS to accommodate 
ANL. Construction of MetRSLeu13Gly variant confirmed that the point mutation 
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conferred the ability to incorporate ANL (>95%) into recombinant proteins like 
Dihydrofolate reductase (DHFR). 
The Schultz group has developed a general scheme based on the orthogonal amber 
suppressor Methanococcus jannaschii tyrosyl-tRNA (MjtRNATyr) and the alteration of 
the substrate specificity of the cognate tyrosyl-tRNA synthetase(MjtTyrRS) in E. coli. A 
random library of MjTyrRS variants is constructed and subjected to a two-step positive 
and negative selection screen. In the first step, MjTyrRS mutants that can successfully 
charge MjtRNA are selected for by incorporating an amber codon into the 
chloramphenicol acteyl transferase gene. Survival on chloramphenicol plates ensures read 
through suppression. In the second step, variants isolated based on the first screen were 
put through a negative selection based on barnase. Amber mutations were introduced at 
permissive sites in the toxic barnase gene and the cells grown in the absence of the non-
natural amino acid. If the synthetase variant could incorporate a natural amino acid at the 
permissive site, the cells would die and would thus be selected against. Using this 
strategy, they have identified MjTyrRS variants that incorporate more than 30 different 




Figure 1.12: “Noncanonical amino acids and tagging reagents. (A) 1, AHA; 2, ANL; 3, 
Tris(triazolyl)amine ligand for copper-catalyzed azide–alkyne ligation; 4, biotin–PEO–
propargylamide; 5, biotin–PEO–cyclooctyne. (B) Scheme for biotin tagging of azide-
functionalized E. coli cell surfaces. 1 or 2 is incorporated into OmpC to display the azide 
on the cell surface. Cell surface azides react either by Cu-catalyzed azide–alkyne ligation 
(top route) or by strain-promoted azide–alkyne ligation (bottom route).” Figure and 
caption reproduced from Link et al. Proc Natl Acad Sci USA (2006), 103, 10180. 





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































It is clear that the utility of modification of enzyme property through directed evolution 
has been demonstrated across all families of enzymes, with diverse reaction chemistries. 
In spite of this, however, developing high-throughput assays for screening large libraries 
(>107 members) remains a formidable challenge. This is especially true for enzymes not 
amenable to genetic selections. The ability to screen large libraries to sift effectively 
through sequence space is particularly important in the context of recognizing novel 
substrates not recognized by the parent enzyme. Yet another and often ignored challenge 
in the alteration of substrate selectivity is the ability engineer enzymes with selectivites 
and activities comparable to the natural enzymes. Indeed, there are very few examples of 
enzymes evolved in vitro that have catalytic efficiencies and substrate profiles that are 
comparable to their natural counterparts (Table 1.1). Although enzymes with higher 
efficiency are almost always desirable, cross-reactivity and specificity depend on the 
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Engineering of Protease Variants Exhibiting High 
Catalytic Activity and Exquisite Substrate Selectivity 
 
2.1 Introduction 
 The reprogramming of enzyme catalytic activity and selectivity is a central issue 
in protein biochemistry and biotechnology.  Numerous structure-guided and directed 
evolution strategies have been employed in search of enzyme variants that exhibit high 
catalytic rates with poor or inactive substrates of the parental enzyme (1-19) (Chapter 1).  
As impressive as these successes have been, the engineering of enzymes that exhibit 
turnover rates and selectivities with new substrates comparable to their natural 
counterparts has proven quite a challenge, especially when considering those enzymes for 
which a genetic selection strategy is not possible.   
In particular, enzymes engineered through laboratory evolution involving in vitro 
catalytic assays have often been found lacking, either with respect to turnover rates or 
selectivity, relative to catalyst-substrate pairs isolated from natural sources.  As a typical 
example, an extensive directed evolution program led to the isolation of E. coli β-
glucuronidase variants with significant β-galactosidase (10) or xylanosidase (11) 
activities, but nonetheless even the best clones exhibited kcat/Km values >1,000 times 
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lower than those of naturally occurring enzymes such as the E. coli β-galactosidase or the 
T. saccharolyticum β-xylosidase.   
This trend appears to be general.  In a recent comprehensive study, Aaron et al. 
(12) demonstrated that the evolution of higher activity towards poor substrates did not 
impair the parental catalytic activity and therefore the evolved enzymes exhibited greater 
promiscuity.  Enzymes evolved for higher substrate enantioselectivity often exhibit lower 
specific activities towards their new substrates relative to their respective parental 
enzymes (13-15).  Similarly, the evolution of highly active variants of aspartate 
aminotransferases capable of accepting branched or aromatic amino acid substrates was 
accompanied by a relaxation of the substrate selectivity (16,17)   
 In nature, the evolution of enzymes occurs as the result of positive selective 
pressure for turnover of physiological substrates, combined with simultaneous negative 
selective pressure in order to eliminate completely, or at least drastically suppress, 
deleterious activities.  It follows that the engineering of enzymes exhibiting high catalytic 
activity and substrate selectivity for a particular desired substrate should be similarly 
accomplished by implementing selection and counter-selection assay schemes in the 
laboratory.  The recent directed evolution of novel tRNA synthetases and recombinases 
by capitalizing on in vivo selections support this expectation (18-19).  Unfortunately, 
many desired enzyme activities are not amenable to in vivo selection strategies because 
cellular growth cannot be linked to the enzyme activity being sought.  Consequently, 
laboratory directed evolution approaches for the isolation of highly selective enzymes 
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must rely on in vitro catalytic assays whereby the activity towards selection and counter-
selection substrates is determined sequentially for each library member (9-11,13,14).  The 
successful implementation of the latter approach hinges on satisfying the following 
requirements:  First, assays that afford the proper dynamic range must be designed since 
mutant proteins are likely to exhibit drastically different kcat and Km values for the various 
selection and counter-selection substrates.  Second, the isolation of rare, high activity 
clones requires the screening of large libraries by assaying each clone towards multiple 
substrates, thus necessitating the availability of suitable high throughput methods.   
With these considerations in mind, we have extended our previous approach (20) 
and developed a new two-pronged strategy in which catalytic activities over a wide 
dynamic range for both a selection substrate and one or more counter-selection substrates 
are quantified simultaneously at the single cell level, enabling the rapid screening of 
mutant libraries.  This approach relies on fluorescent substrates of different colors that 
label the surface of E. coli cells upon cleavage by a surface-anchored enzyme (20).  
Enzymes can be displayed on the surface of Gram-negative bacteria by established 
techniques (21,22) and thus, access to the fluorescent substrate is assured.  The net result 
is that the cell fluorescence profile accurately reflects the catalytic activity and selectivity 
of the surface displayed enzyme.  Multi-parameter flow cytometry is then employed to 
isolate clones expressing enzymes having a desired fluorescence profile from large 
libraries.   
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 The E. coli endoprotease OmpT and its Omptin homologues play important roles 
in pathogenicity, are of significance in protein manufacturing, and have been exploited 
for biotechnology applications (23,24).  OmpT has a strong preference for cleavage 
between two basic residues (Lys and especially Arg) in the P1 and P1’ positions of the 
substrate (25-27).  We sought to isolate OmpT variants that exhibit (1) hydrolysis of a 
substrate that is cleaved poorly by the wild-type enzyme, and (2) a low rate of cleavage 
of dibasic sequences (preferred by the wild-type enzyme) thus conferring (3) a high 
selectivity for the new cleavage over the one preferred by the parental enzyme (Figure 
2.1A), while maintaining (4) a very high level of catalytic activity.   
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Figure 2.1. (A) Two-color discrimination and selection using the FRET and electrostatic 
capture substrates; (B) Library sort gate R3, used to isolate positive clones displaying 
high FL-1 (from the hydrolysis of 1) and low FL-2 (lack of hydrolysis of 2) fluorescence.   
 
 65
2.2 Materials and Methods 
Substrate synthesis.  
The peptides 1a Ac-CARVGKGRGR-NH2 and 2a Ac-EEGGRRIGRGGK-NH2, 
were synthesized at the University of Texas Peptide synthesis facility. 
Tetramethylrhodamine-5-iodoacetamide (TMRIA), 5- carboxytetramethylrhodamine, 
succinimidyl ester (5-TAMRA, SE) and BODIPY®-FL-SE were purchased from 
Molecular Probes, Eugene, OR. The peptides 3 WCARVGKGRGR-NH2 and 4 
WEEGGRRIGRGGK-NH2 (>95% purity) were purchased from Cell Essentials (Boston, 
MA).  
For the synthesis of the FRET substrate 1, a 50 μL solution the 1a (5.4 mg, 4.9 
μmol) in water was added to 100 μL of 1M Na2CO3 and 50 μl of 0.5M NaHCO3.  A 
solution of 50 μL of TMRIA (4.0 mg, 4.8 μmol) in DMF was added to the reaction 
mixture and stirred at RT for 1h.  The reaction mixture was quenched with 5 ml of 0.1% 
TFA in water and the product purified by FPLC using a 10% -30% acetonitrile gradient. 
The purified product (2.6 mg, 35% yield) was freeze-dried, dissolved in 500 μL of water 
and its identity was confirmed by both 1H-NMR and ESI-MS.  For the conjugation of 
BODIPY a 90 μL solution of the purified product (1.9 mg, 1.2 μmol) in water, was mixed 
with a 90 μL solution of BODIPY®-FL-SE (0.5 mg, 1.3 μmol) in DMF.  25μL of 1M 
DMAP (25 μmol) was added to the reaction mixture and stirred at RT for 1h. The 
reaction mixture was quenched with 5ml of 0.1% TFA in water and purified by FPLC 
 66
with a 10% -30% acetonitrile gradient. The purified product (0.7 mg, 32% yield) was 
freeze-dried, dissolved in 500 μL of water and quantified by UV. The product identity 
was confirmed by both 1H-NMR and ESI-MS. 
The electrostatic capture substrate 2 was synthesized exactly as described above 
for BODIPY conjugation, except that 5-TAMRA, SE was used instead of BODIPY®-FL-
SE. 
 
Flow cytometric analysis: E.coli UT5600 (F- ara-14 leuB6 secA6 lacY1 proC14 tsx-67 
Δ(ompT-fepC)266 entA403 trpE38 rfbD1 rpsL109(StrR) xyl-5 mtl-1 thi-1) was 
transformed with pML19 (28) encoding wild-type OmpT under the control of its native 
promoter. Overnight cultures of UT5600, UT5600/pML19 were resuspended in 1% 
sucrose, diluted to 0.01 OD600, labeled for 10 min with 50 nM 1 in 1% sucrose, diluted 
into 1 ml 1% sucrose, and analyzed using a Becton-Dickinson FACSort. 
 
Molecular Biology methods A library of random mutants was constructed by error-
prone PCR using Clonetech’s (Palo Alto, CA) Diversify mutagenesis kit.  The PCR 
product, pAMP1 vector DNA (Life Technologies, CA), annealing buffer, and 2 units 
Uracil DNA glycosylase in a total volume of 20 μl were incubated for 40 minutes at 
37oC, followed by 1 hour at 4oC.  The reaction mixture was used to electroporate 
electrocompetent E. coli DH10B (F- mcrA ∆(mrr-hsdRMS-mcrBC) φ80lacZ∆M15 
∆lacX74 recA1 endA1 araD139 ∆(ara, leu)7697 galU galK λ- rpsL nupG ) cells and the 
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entire library was plated on selective media.  The clones were pooled and frozen at –80°C 
in aliquots. 
OmpT mutants in which Ser223 was substituted with Arg, Gly, Leu, Lys, Phe or 
Trp were constructed using the QuikChange® Site-Directed Mutagenesis Kit (Stratagene, 
La Jolla CA) with pML19 as the template and appropriate overlapping primer pairs.  
 
Library Screening:  Transformants were grown at 37oC in LB media, harvested after 16 
hours, washed once with 1% sucrose and resuspended in 1% sucrose. A 50 μL aliquot of 
the cell suspension in sucrose was added to 949 μl of 1% sucrose and labeled using 1 μl 
of each 1 & 2 (final concentration 100 nM). A 20 μL aliquot of this labeling reaction was 
diluted into 1% sucrose and analyzed on the flow-cytometer.  Library sorting was 
performed on a Becton Dickinson FACSCalibur instrument, using gates set based upon 
FSC/SSC and FL1/FL2 values.  A total of ~3x106 cells were sorted in 29 min and 1050 
clones were isolated and then resorted. The collected solution was filtered, and the filters 
were placed on agar plates containing 200 µg/ml ampicillin.  After 14 hours, 99 colonies 
that grew were individually inoculated into 1 ml LB media containing 200 μg/ml 
ampicillin.  Individual colonies were screened using either substrate 1 or 2 on the flow-
cytometer using the exact same protocol described above.  
 
Enzyme purification and kinetic analysis. Proteins were isolated as previously 
described, with minor modifications (20) to a final purity >90% as determined by SDS-
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PAGE. For kinetic analyses, 10-20 nM of the purified enzymes were incubated with 20 
μM to 1 mM of the appropriate substrate in 0.1 M Tris, 10 mM EDTA, pH 8.0 at room 
temperature (25oC) and the reaction was monitored by HPLC on a Phenomenex C18 
reverse phase column using the following gradient: 5% AcN/95% H2O for 1 min, 
increasing to 95% AcN/5% H2O over a period of 29 mins and returning to 5% AcN/95% 
H2O over 5 mins. The product concentration was determined using the integration areas 
at 280 nm and the apparent rates were fitted to a Michaelis-Menten by non-linear 
regression. The cleavage products were determined by LC-MS (ESI) on a Magic 2002 
instrument (Micron Bioresources, Auburn, CA). 
 
2.3 Results  
Two color Flow Cytometric Screening Strategy:  Electrostatic interactions between the 
negatively charged bacterial surface (29) and substrates 1 and 2 (Figure 2.2) were 
exploited to capture the fluorescent and positively charged products of the enzymatic 
cleavage reaction on the surface of the bacteria.  The selection substrate 1 is a FRET 
peptide with a net +3 charge, the minimum charge required for cell surface capture (30).  
1 is electrostatically adsorbed on the cell surface but upon cleavage, the N-terminal 
moiety consisting of Ac-NH2-CA bound to the tetramethylrhodamine (TMR) dye is 
released from the cell, resulting in accumulation of the C-terminal peptide, which is 
positively charged and contains the BODIPY® (4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-
diaza-s-indacene-3-propionic acid) fluorophore.  Substrate 1 was used as the selection 
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substrate because it accumulates on the cell surface prior to cleavage, resulting in a high 
effective molarity, which in turn, enables the detection of even very weak catalytic 
activity. The counter-selection substrate 2 was a zwitterionic peptide containing a single 
fluorophore and at least three positive charges on one side of the scissile bond (Arg-Arg), 
as well as an equal number of negatively charged groups on the other (Figure 2.1A) (The 
counter-selection substrate scheme was devised by Jongisk Gam from our group).  The 
intact substrate has no net charge, but enzymatic cleavage generates a positively charged 
moiety carrying the fluorescent dye that is deposited on the cell surface.  Upon incubation 
with 2, ompT+ cells exhibited a >10 fold higher fluorescence relative to the E. coli ompT- 
deletion strain UT5600 (data not shown).  The combination of a surface bound selection 
FRET substrate 1 and zwitterionic counter-selection substrate 2 that is free in solution 
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Figure 2.2:  Substrates used for the detection of catalytic activity and for the kinetic 
analysis. 
 
Library Screening: C5 is an OmpT variant exhibiting a 60-fold increase in activity 
towards cleavage at a non-preferred Arg-Val site (20).  However, as is typically the case 
for engineered enzymes, C5 exhibits relaxed overall specificity, and is not selective for 
the cleavage of Arg-Val sites.  For example, the C5 variant also cleaved peptide 
substrates at Ala-Arg sequences with a catalytic efficiency even higher than that of the 
wild-type OmpT (Table 2.1) as well as other sequences (20).  The gene encoding C5 
downstream from the ompT promoter was subjected to random mutagenesis by error-
prone PCR (30) and a library of approximately 1 x 106 transformants was generated.  
DNA sequencing of 10 randomly selected clones revealed a mutation rate of 1.1% 
nucleotides per gene.  The E. coli library was incubated in a solution of 1% w/v sucrose 
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(to maintain proper osmotic balance) together with 100 nM of the electrostatic capture 
substrate 2 and the FRET substrate 1 for 10 minutes.  Bacterial cells displaying increased 
BODIPY® fluorescence (green, emission at 530 nm, FL-1) and reduced TMR 
fluorescence (red, emission at 560 nm, FL-2) corresponding to high activity with 
substrate 1 and reduced activity with the counter-selection peptide 2, respectively, were 
isolated (Figure 2.1B).  A total of 1050 clones were obtained and following resorting, 99 
clones were isolated, grown individually in microtiter well plates.  Two clones, 1.3.19 
and 1.2.19, were selected for further study because they both exhibited high green 
fluorescence (Figure 2.3) and reduced red fluorescence consistent with the sorting criteria 
used for their isolation.  Sequencing determined that 1.2.19 (Table 2.2) contained 
Asp208Gly and Asp214Val mutations whereas 1.3.19 contained Ser17Gly and 
Ser223Arg mutations in addition to those found in C5, the parent enzyme used in this 























Figure 2.3: Flow-cytometric discrimination of E. coli UT5600 (ΔompT) transformed with 
pML19 (expressing wt OmpT), pML1.2.19 and pML1.3.19 using FRET substrate 1. 
Briefly, the cells were washed and resuspended in 1% sucrose and labeled with 50nM 
(final concentration) of the AR-FRET substrate 1. A 20ul aliquot of the labeling reaction 









-A-R- 1 -R-R- 2 Specificity Enzyme 
kcat (s-1) KM (uM) kcat/KM
 (s-1M-1) 
kcat (s-1) KM (uM) kcat/KM
 (s-1M-1) 
-AR-/-RR- 
        
OmpT  3.1±0.5 x10-2 16±5 2.2±0.9 x103 8.8±0.7 55±9 1.7±0.4 x105 1.3 x 10-2
C5 1.7±0.5x10-2 1.5± 0.6 1.4±0.8 x104 0.7± 0.1 2.2 ±0.4 3±1.0 x105 3.6x 10-2
1.2.19 1.7±0.3 9±1 2.1±0.6 x105 0.4±0.1 260±90 2±1 x103 1.0x 102
1.3.19 2.2±0.4 15±3 1.5±0.1 x105 4.9±0.6x10-4    160±30 3±1 4.7 x 104
S223R 2.3±0.1 9±2 2.6±0.8 x105 n.d. n.d. n.d. >1.8 x 105
D208G 1.6±0.1 7.3±0.8 2.4±0.7 x105 0.3±0.1 240±100 2±1 x103 1.4 x 102
 
Table 2.1: Kinetic parameters for the cleavage of substrate 3 & substrate 4 by OmpT, C5 
and the four mutants. Reactions were carried out at room temperature.   
1 Substrate sequence: WCARVGKGRGR-NH2
2 Substrate sequence: WEEGGRRIGRGGK-NH2 








Enzyme 17 33 87 111 137 149 186 200 208 214 223 288 
WT Ser Glu Met Glu Ser Ile Ser Tyr Asp Asp Ser Ile 
C5 Ser Lys Leu Val Asn Val Cys Phe Asp Asp Ser Phe 
1.2.19 Ser Lys Leu Val Asn Val Cys Tyr Gly Val Ser Phe 
1.3.19 Gly Lys Leu Val Asn Val Cys Phe Asp Asp Arg Phe 
 
Table 2.2: List of mutations in WT OmpT, C5, 1.2.19 &1.3.19. The changes in 1.2.19 
and 1.3.19 relative to their starting parent, C5, are highlighted in blue. 
 
The 1.2.19 and 1.3.19 proteins were extracted in n-octyl-β-glucoside and purified (25).  
Kinetic analysis of the purified OmpT 1.2.19 and 1.3.19 (Table 2.1) proteins using 
unlabeled peptide substrates 3 and 4 (Figure 2.2) revealed that the selection yielded the 
anticipated outcome, namely, highly active enzymes that are specific for the hydrolysis of 
3, in particular cleavage of the Ala-Arg peptide bond, but are impaired in their ability to 
attack Arg-Arg. It is interesting to note that although cleavage between any two amino-
acids in the linker region between the fluorophore and the quencher would lead to 
increased FL-1 fluorescence, the two best variants 1.2.19 and 1.319 cleaved substrate 3 
between Ala-Arg.  In addition 1.3.19 did not exhibit the secondary cleavage activities 
displayed by its parental enzyme C5.  Importantly, compared to the wild-type OmpT, 
1.3.19 displayed a more than 3x106 reversal in selectivity (Table 2.1) for Ala-Arg over 
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Arg-Arg cleavage, but its enzymatic activity for cleavage of 3 (kcat/KM = 1.5x105 s-1M-1) 
was nearly identical to that of the wild-type OmpT for its own preferred substrate 4 
(kcat/KM = 1.7x105 s-1M-1).  The isolation of both 1.2.19 and 1.3.19 suggests that such 
highly selective, highly active catalysts, as opposed to enzymes with expanded specificity 
or low catalytic activity towards new substrates, can be easily isolated by multi-
parameter, quantitative screening of large libraries.   
 
Site Specific OmpT Mutants:  With the exception of the Ser17Gly mutation in 1.3.19, 
the other three amino acid substitutions in the two isolated clones resulted in mutations 
that involved charged residues.  Examination of the recently reported structure of OmpT 
(31) pointed to a significant role for Ser223Arg and Asp208Gly in modulating peptide 
substrate specificity, since these residues are located deep in the active site cleft.   
Ser223Arg and Asp208Gly were constructed using site directed mutagenesis and 
purified as above.  An LC-MS of the substrate cleavage products revealed that the OmpT 
Ser223Arg and Asp208Gly enzymes cleaved 3 only between Ala-Arg.  Neither variant 
produced the secondary Lys-Gly cleavage that is generated by the wild-type OmpT 
(kcat/KM = 4x103 s-1M-1) as well as the C5 enzyme.  In addition, the single amino acid 
variants recapitulated the high selectivities and catalytic activities displayed by 1.2.19 
and 1.319, respectively (Table 2.1).  In particular, Ser223Arg completely abolished the 
ability of OmpT to cleave Arg-Arg sites (no cleavage of 4 could be detected following 
>24 hr incubation) yet cleaved 3 at Ala-Arg with a kcat/KM value slightly higher than 
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1.3.19.  In addition, the Ser223Arg mutant did not cleave substrate 5 (Figure 2.2), further 
underscoring its specificity for Ala-Arg.   The effect of the Ser223Arg mutation appeared 
to be unique, since insertion of Trp, Lys, Leu, Gly, or Phe at the 223 position using site 
directed mutagenesis resulted in variants that did not exhibit cleavage of substrate 1 
comparable to even wt OmpT when monitored by FACS (Figure 2.4).   
 
Figure 2.4: Flow-cytometric analysis of the OmpTSer223 mutants. Briefly, the cells 
were washed and resuspended in 1% sucrose and labeled with 50nM (final concentration) 
of the AR-FRET substrate 1. A 20ul aliquot of the labeling reaction was transferred to 




We have developed a high throughput strategy for the quantitative screening of 
enzyme libraries using simultaneous selection and counter-selection criteria.  The 
methodology presented depends on: (1) the display of enzyme libraries on the surface of 
microorganisms; (2) retention of fluorescent reaction products on the cell surface and (3) 
multicolor flow cytometry for the isolation of clones that can selectively turn over one or 
more substrates.  The combination of electrostatic and FRET substrates afforded the 
proper dynamic range required to screen a wide array of enzymatic activities, an 
important consideration when screening large enzyme libraries.  
Display of enzymes on the surface of microorganisms such as E. coli or yeast can 
be accomplished in a variety of ways (32,33).  In this manner, the enzyme can react with 
exogenous synthetic substrates, circumventing the substrate transport limitations 
associated with methods that use intracellularly expressed enzymes.  In our approach, the 
enzymatic reaction generates fluorescent products that become associated with the cell 
surface resulting in a fluorescence profile representative of the catalytic selectivity of the 
displayed enzyme.  Although we have capitalized on electrostatic interactions for product 
capture, a number of other methods for cell surface modification (34,35) may be 
exploited for the capture of reaction products.  In addition to the directed evolution of 
protease selectivity reported here, we believe that our methodology can be extended to 
other enzymes including various hydrolases and ligases.  For example, studies to engineer 
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stereo- and enantio- selective variants of the small esterase cutinase are on-going in our 
laboratory. 
We screened an OmpT error-prone library in order to select for variants that 
preferred a new peptide substrate at the expense of activity with the wild-type preferred 
substrate.  After three rounds of sorting we obtained 10 clones that displayed the desired 
specificity profile, the best of which were 1.219 and 1.3.19.  Although the targeted error-
rate for the library was 1.1% (11 bases), both 1.2.19 (Asp208Gly, Asp214Val) and 1.3.19 
(Ser17Gly, Ser223Arg) had just two extra mutations each, relative to C5 (20), the starting 
enzyme construct.  A detailed kinetic analysis of the isolated enzymes proved both to be 
consistent with the flow-cytometric screening criteria.  In other words, both of these 
enzymes have altered as opposed to relaxed substrate specificity, yet maintain a native 
level of catalytic activity.  
Examination of the crystal structure of OmpT (31) indicated that the Asp208Gly 
mutation in 1.2.19 and the Ser223Arg in 1.3.19 might be the primary determinants of the 
altered specificity profiles of these enzymes.  Construction of these single point mutants 
of OmpT confirmed that Asp208Gly was similar to 1.2.19 in terms of specificity and 
overall activity.  Unexpectedly, Ser223Arg was more specific than 1.3.19, especially in 
eliminating cross-reactivity with the wild-type preferred Arg-Arg containing substrate 4.  
Importantly, the Ser223Arg variant was as active with substrate 3 as wild-type OmpT 
with its preferred substrate 4.  Thus, for the Ser223Arg single mutation variant of OmpT, 
altered specificity has not come at the cost of overall catalytic activity. 
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It is worth mentioning that while OmpT is a trypsin-like protease (36), the 
Ser223Arg substitution conferred specificity more analogous to that of chymotrypsin.  
The effect of this single amino acid substitution should be contrasted with the conversion 
of trypsin to chymotrypsin that required a monumental effort and hinged on major 
reorganization of the substrate-binding surface (37,38).  
 A crystal structure of OmpT has been published (31), but no structural 
information is available for OmpT containing a bound substrate or substrate analog.  
Nevertheless, inspection of the OmpT structure leads to a reasonable prediction for the 
location of an unusually deep S1 binding pocket (Figure 2.5), with the Ser223 residue 
located near the bottom of this pocket.  Consistent with our proposed role of the 223 
residue in substrate recognition, a recent MD calculation using wild-type OmpT and an 
Arg-Arg containing substrate placed the P1 Arg side chain deep in the same S1 pocket 




Figure 2.5:  (A) The electrostatic potential surface of OmpT (31) generated using 
WebLab ViewerLite (Accelrys, San Diego, CA) (B) The side-chains corresponding to 
Asp208 and Ser223 are shown in addition to the proposed catalytic residues, Asp83, 
Asp85, and Asp210 & His212. 
 
The high activity seen with Ser223Arg likely reflects a simple swapping of an 
important residue from the peptide substrate to the enzyme active site.  Because enzymes 
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evolve to be catalytically active in the presence of substrate, it makes sense that some 
functional groups attached to the substrate could modulate active site structure and thus 
catalytic activity to a significant degree.  This is the basis of Koshland’s induced fit 
theory of enzyme catalysis (40) in which substrate binding is required to convert an 
enzyme active site into the proper catalytic arrangement.  A logical interpretation of our 
data is that the Ser223Arg substitution replaces important induced fit interactions of the 
P1 Arg side chain of a bound substrate (Figure 2.6) with the 223Arg side chain that is 
now attached to the enzyme in S1.  A significant structural role for the restored guanidium 
group would explain why the Ser223Arg variant has wild-type levels of catalytic activity.  
Interestingly, the decreased rate of catalysis seen for wild-type OmpT reacting with the 
non-preferred substrate 3 (that lacks the P1 Arg residue) is primarily a reflection of a 
substantially lower kcat value, possibly consistent with the induced fit hypothesis that a 
guanidium group in the P1-S1 site is important for high levels of catalytic activity.  In 
order to investigate this hypothesis, we constructed five OmpTSer223 mutants, 
OmpTSer223Phe, OmpTSer223Gly, OmpTSer223Lys, OmpTSer223Leu and 
OmpTSer223Trp. These five mutants were designed to test if the guanidium group is 
essential in P1-S1 site for high catalytic activity or if steric (Phe, Trp), hydrophobic (Leu) 
or positively charged (Lys) residues can help achieve the same goal. Flow-cytometric 
analysis (Figure 2.4) demonstrates that none of these mutants had even a wild-type level 
of activity with substrate 1, confirming the need for a guanidium group. On-going studies 
will elucidate whether the generation of equally active enzymes selective for different S1 
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occupancies, for example cleavage of Asp-Arg, Trp-Arg, or Arg-Ala sequences, can be 











OmpT-Ser 223 OmpT-Arg 223
S1 Pocket S1 Pocket  
 
Figure 2.6. Arginine side-chain swapping.  The Arg occupying the P1 subsite is 
accommodated by Ser223 in S1.  In the 1.3.19 mutant the Ser223Arg only allows 
occupancy by Ala in the P1 site of the substrate.   
 
Swapping important residues at protein-protein and protease-substrate interfaces 
has been accomplished by rational design (41,42).  For 1.3.19, this apparent swapping 
occurred as a result of combined selection and counter-selection.  In that regard, the 
isolation of the OmpT Ser223Arg variant supports the notion that residue swapping at 
protein-peptide interfaces represents a facile mechanism for substrate diversification as 
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the result of evolutionary pressure without any preconceived notions regarding the 
protein structure. 
Impressive as our findings with OmpT Ser223Arg might be, in general, the 
engineering of large changes in substrate specificity is expected to require multiple amino 
acid substitutions leading to extensive remodeling of the active site.  Thus, while in this 
case, the Ser223Arg mutant could have been identified by screening a small library using 
manual techniques, the evolution of mutants of OmpT or other enzymes that can react 
selectively with non-native substrates will likely require the screening of very large 
libraries.  Therefore, a high overall assay throughput/dynamic range and the ability to 
place selection and counter-selection evolutionary pressure on an enzyme to be evolved 
are key to the isolation of rare, change-of function clones.  Selection and counter-
selection assays can be carried out in a tiered approach, wherein the library is screened 
first for one substrate and then the active clones are screened for activity with the 
counter-selection substrate. As shown here, however, selection and counter-selection can 
also be applied simultaneously, analogous to living systems. Simultaneous screening by 
FACS accommodates high throughput and is particularly attractive for carrying out 
evolutionary experiments using three or more substrates, as required to explore “substrate 






We have a developed a new two-color flow-cytometric dual-color selection and counter-
selection assay for the quantitative screening of libraries the E. coli surface displayed 
protease OmpT. The application of this assay towards altering the P1 specificity of OmpT 
to hydrolyze Ala↓Arg substrate was demonstrated. Although the engineered enzyme had 
just one amino acid change, it showed a 3 million-fold change in selectivity (-Ala-Arg-/-
Arg-Arg-) and a catalytic efficiency for Ala-Arg cleavage that is the same as that 
displayed by the parent for the preferred substrate, Arg-Arg. The engineered variant was 
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    Chapter 3 
      High-throughput protease engineering 
 
3.1 Introduction 
Proteases are ubiquitous proteins that play a key role in a wide range of physiological 
processes such as protein turnover(1), apoptosis (2) and signaling, (3). Proteases 
represent one of the most well-studied and characterized enzyme classes (4-6). In spite of 
the great body of work dedicated to the understanding of the mechanistic aspects of 
protease catalysis (7) and their substrate specificity (8), designing high-throughput assays 
for the engineering of protease specificity has been challenging. The two main obstacles 
for high-throughput protease screening in vivo are expression and selection. Expression 
of soluble proteases in vivo is hampered by cytotoxicity, due to cleavage of essential 
physiological proteins (9) and auto-proteolysis. And unlike the selection for affinity, 
wherein binding maintains the link between genotype and phenotype (For a review on in 
vitro protein evolution please see (10)), designing high-throughput selection for catalytic 
turnover in a quantitative manner is significantly more complex.  
OmpT is a non-essential E. coli outer membrane endopeptidase that cleaves between 
dibasic residues (11) and has been implicated in pathogenicity (12). OmpT is a trypsin-
like protease in that the requirement for Arg in P1 is strict, while it can tolerate multiple 
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residues in P1’ (although Arg is still preferred) (11). Similar to other E. coli outer 
membrane proteins, the protein is translated with a leader peptide, translocated across the 
cytoplasmic membrane and folded into its final active conformation in the outer-
membrane (13). The catalytic core of OmpT is directed towards the external environment 
and thus has no access to the soluble proteins of the cell (14). 
We had previously reported a high-throughput flow-cytometric, dual color, selection and 
counter-selection assay for the directed evolution of OmpT variants (Figure 2.1, Chapter 
2) (15). The selectivity profile of the outer-membrane protease gives rise to a multi-color 
profile. Flow-cytometry is then used to isolate cells that show the desired fluorescence 
characteristics. In the current work, the application of the two-color flow-cytometric 
assay to systematically engineer the substrate specificity of OmpT is demonstrated. 
 
3.2 Materials and Methods 
Substrate synthesis.  
The peptides 1a-5a Ac-CXRVGKGRGR-NH2 (X=A/P/T/E/Y), 7a Ac-
CEAVGKGRGR-NH2 and 6a Ac-EEGGRRVGKGRGR-NH2, were synthesized at the 
University of Texas Peptide synthesis facility. QSY®7 C5 maleimide, 5- 
carboxytetramethylrhodamine, succinimidyl ester (5-TAMRA, SE) and BODIPY®-FL-
SE were purchased from Invitrogen (Carlsbad, CA). The peptides 1-5 
WXARVGKGRGR-NH2  (X=A/P/T/E/Y), 7 WCEAVGKGRGR and 6 
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WEEGGRRVGKGR-NH2 (>95% purity each) were purchased from EZBiolab 
(Westfield, IN).  
The conjugation of fluorophores to the substrates 1a-7a was performed essentially 
as described before (15). 
 
pDMLE19 plasmid construction:  In order to construct an expression vector for the 
cloning of OmpT libraries downstream of its native promoter, the EcoRI restriction site in 
pUC19 was removed as follows. 5ug of pUC19 was digested with 25U of EcoRI in a 
50μl reaction incubated at 37oC for 3h. The product was gel-purified incubated with 
33uM (final concentration) dNTPs and 1.25U of the Klenow fragment of the DNA 
polymerase in a 50ul reaction volume at 25oC for 15min. At the end of the reaction, 10μl 
of 50mM EDTA was added and the enzyme heat inactivated by incubation at 75oC for 
20min. The product was gel-purified and blunt-end self-ligated using T4 DNA ligase, 
transformed and sequenced to confirm removal of the EcoRI site and labeled pDUCE19. 
The ompT upstream region containing its native promoter was amplified using the 
primers 5’ CGCGGATCCGATTCGAACCTGCGGGC 3’ and 5’ 
CCGGAATTCTTAAAATGTGTACTTAAC 3’. The ompT gene was amplified from 
plasmid pML19 (16)(REF) as the template with the primers 5’ 
AAACGATTGAATGGAGAATTCACCATCGGGCGAAACTTCTG 3’ & 5’ 
AACAGCCAAGCTTTTAAAATGTGTACTTAAGACCAGCAGT 3’.The two different 
PCR products were gel-purified and 50ng of each fragment was mixed together and 
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reamplified using the primers 5’ CGCGGATCCGATTCGAACCTGCGGGC 3’ and 5’ 
AACAGCCAAGCTTTTAAAATGTGTACTTAAGACCAGCAGT 3’.The resulting 
PCR product was digested with BamHI & HindIII and ligated into pDUCE19 cut with the 
same restriction enzymes. Transformation and sequencing confirmed the construct 
pDMLE19. This construct has the EcoRI site right before the ATG start site allowing 
easy cloning of the libraries. 
 
Library construction  
Error-prone libaries:  Random mutagenesis was performed by error-prone PCR 
amplification using the ompT gene/ompT mutants as the template and the primers 5’ 
CCGGGAATTCACCATGCGGGCGAAACTTCTGGGAATAGTC 3’ and 5’ 
AACAGCCAAGCTTTTAAAATGTGTACTTAAGACCAGCAGT 3’. The error-rates 
were varied between 0.6%-1.0%.  Denaturation was performed by heating to 95oC, 2 min 
16 cycles – 95oC, 1 min / primer annealing was performed at 52oC, 1 min / and primer 
extension was carried out at 72oC, 3 min; 72oC, 10 min. The PCR products were run on a 
0.8% agarose gel and purified using the QIAGEN QIAquick gel extraction kit. The 
purified DNA was digested with EcoRI and HindIII overnight at 37oC and heat 
inactivated at 65oC for 20 min. Digested product was run on a 0.8% agarose gel, 
QIAGEN purified and the amount of DNA quantified. The vector pDMLE19 was 
similarly digested, dephosphorylated and purified. Ligation reactions were 
performedusing 100 ng (50 fmol) of the digested vector and a 3-fold molar excess of the 
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insert at 25oC for 4 h. The ligation reactions  were heat inactivated at 65oC for 20 min and 
desalted on a nitrocellulose membrane for 1h. A 3 μl aliquot of the desalted ligation 
reaction was transformed with 40 μl of electrocompetent MC1061 (araD139 Δ (ara-leu) 
7696 Δlac174 galU galK hsr- hsm+ strAR) cells.  Following incubation in 1ml SOC at 
37oC for 1 h the entire transformation mixture was plated on LB 1% glucose plates 
containing 200 μg/ml ampicillin to yield ~2x108 independent transformants. After growth 
at 37oC for 8 h the cells on plates were scraped using 2 ml LB, pooled together and 1 ml 
of the pooled, scrapped cells was used to inoculate 1 L of LB 1% glucose containing 200 
μg/ml ampicillin. The cells were grown in LB/ampicllin 1% glucose at 25oC for 5 h. 
Plasmid DNA was then isolated, re-transformed into electrocompetent E. coli 
BL21(DE3) (F- ompT  hsdSB(rB- mB-) gal dcm (DE3)) and the cells grown to an OD600 of 
2 units in 1 L of 2xYT containing 200 μg/ml of ampicillin at 37oC for library screening. 
NNS libraries:  The entire ompT gene was assembled based on a set of 48 primers 
designed to include a 5’ EcoRI cut-site and a 3’ HindIII cut site for ligation into the 
pDMLE19 vector. Denaturation of the double-stranded template was performed at 95oC, 
1 min; 54 cycles – 95oC, 30s /primer annealing was carried out at 45oC, 30s / and primer 
extension was performed at 72oC, 30 s. A 2 μl aliquot of the first PCR reaction was used 
as template to for a second PCR reaction, amplified using the outside primers 5’ 
CCGGGAATTCACCATGCGGGCGAAACTTCTGGGAATAGTC 3’ and 5’ 
AACAGCCAAGCTTTTAAAATGTGTACTTAAGACCAGCAGT 3’.  Denaturation of 
the double-stranded template was performed at 95oC, 2 min; 29 cycles – 95oC, 30 s / 
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primer annealing was carried out at 60oC, 30 s  / and primer extension was performed at 
72oC, 90s; 72oC, 10 min. The PCR product was then gel-purified, digested and ligated 
into pDMLE19 as described above. In order to construct the saturation library, Sat3, 
PAGE-purified primers containing NNS at codons 27,208 and 223 were used for the gene 
assembly PCR reaction. The library Sat7 was constructed using randomized NNS primers 
encoding for residues 27, 29, 39, 40, 42, 208 and 223 in the assembly PCR reaction. For 
the construction of the 90% NNS library, a 9:1 mix of the NNS primers and the wild-type 
codon primers corresponding to residues 27, 29, 39, 40, 42, 44, 81, 87, 97, 101, 148, 150, 
153, 163, 170, 208, 221, 263, 265, 280 and 282 were used to assemble the gene. 
 
Library Screening: The plasmid library (construction and isolation of plasmid library 
described above) was transformed into electrocompetent E. coli BL21(DE3) (F- ompT  
hsdSB(rB- mB-) gal dcm (DE3)) and the cells grown to an OD600 of 2 units in 1 L of 2xYT 
containing 200 μg/ml of ampicillin at 37oC (6-8 h). An aliquot of the cells adjusted to an 
OD600 of 2 units (1 ml) were centrifuged at 10Krpm for 2 min using a micro-centrifuge.  
The supernatant was discarded and the cells were resuspended in 1 ml of 1% sucrose. 
Following resuspension, the cells were again spun down at 10 Krpm and resuspended in 
1ml 1% sucrose. A 5 0μL aliquot of the cell suspension was added to 948 μl of 1% 
sucrose and labeled using 1 μl of the appropriate selection substrate (final concentration 
20 nM) and 1μl of the counter-selection substrate Arg-Arg (final concentration 100 nM). 
An 800ul aliquot of this labeling reaction was diluted into 200 μl of 1% sucrose and 
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analyzed on the flow-cytometer.  Library sorting was performed on a Dako MoFlo® 
instrument, using gates set based upon FSC/SSC and FL1/Compensated FL2 values.  A 
total of ~2x107 cells were screened using three separate labeling reactions and ~1% of the 
most fluorescent cells were sorted into 3 ml of 2xYT. The cells were grown to an OD600 
of 2 units, resorted and the process repeated until the mean fluorescence of the highly 
fluorescent population remained constant.  After 5-7 rounds of sorting and resorting the 
cells were plated on selective media and individual colonies were analyzed on the flow-
cytometer. 
 
Flow-cytometric OmpT activity assays: Single colonies from a plate were used to 
inoculate 2 ml 2xYT cultures containing 200 μg/ml of ampicillin. The cells were grown 
to an OD600 of 2 units, centrifuged at 10 Krpm for 2 min, washed once with 1 ml of 1% 
sucrose and resuspended in 1ml of 1% sucrose. For labeling, 50 μl of the cells were 
diluted into 949 μl of sucrose and 1μl of the substrate (final concentration 20 nM for 1-5 
and 100nM for 6). A 20 μl aliquot of the labeling reaction was diluted into 0.5 ml of 1% 
sucrose and analyzed on Becton Dickinson FACSSort. 
 
Enzyme purification and kinetic analysis. Proteins were isolated as previously 
described, with minor modifications (15) to a final purity >90% as determined by SDS-
PAGE. For kinetic analyses, 0.5-20 nM of the purified enzymes were incubated with 20 
μM to 1 mM of the appropriate substrate in 0.1 M Tris, 50 μM TCEP, 10 mM EDTA, pH 
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6.1 at room temperature (25oC) and the reaction was monitored by HPLC on a 
Phenomenex C18 reverse phase column using the following gradient: 5% AcN/95% H2O 
for 1 min, increasing to 95% AcN/5% H2O over a period of 29 mins and returning to 5% 
AcN/95% H2O over 5 mins. The product concentration was determined using the 
integration areas at 280 nm and the apparent rates were fitted to a Michaelis-Menten by 
non-linear regression. The cleavage products were determined by LC-MS (ESI) on a 
Magic 2002 instrument (Micron Bioresources, Auburn, CA). 
 
Plasminogen activation assays:  Stock solutions of Spectrozyme ®PL (5.0 mM) and 
human glu-type plasminogen (0.5 mg/ml) were made in 50 mM Tris, 0.01% Tween 20, 
pH 7.4. To 44 ml of 50 mM Tris, 0.01% Tween 20, pH 7.4 was added 5ml of 
Spectrozyme PL (final concentration 0.5 mM) and 1 ml of plasminogen to make up the 
working solution. To 200 μl of the working solution was added 0.2-5.0 μg of the purified 
enzyme (vtPA (American Diagnostica, Stamford, CA)) /eRV6/OmpT) and the reaction 
kinetics monitored at 405nm on a BioTek Synergy HT (BioTek instruments, Winooski, 
VT) at 37oC.  In order to estimate if the enzymes had any activity towards hydrolyzing 
the chromogenic substrate, identical assays were run in the absence of plasminogen. 
 
T7 RNA polymerase digests: 300 U of T7 RNA polymerase (Ambion Inc, Austin, TX) 
was incubated with ~50-200 ng of OmpT/OmpT variants 10 mM MES (2-
morpholinoethanesulfonic acid), 10 mM EDTA, pH=6.1 in a 30μl reaction volume at 
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37oC for 3 h. 15μl of the reaction mixture was mixed 15 μl of 2X SDS page loading 
buffer containing DTT and run on a 12% Tris-glycine gel. The sites of cleavage were 
confirmed using N-terminal sequencing. 
 
Site-directed mutagenesis: Site-directed mutagenesis was performed using the 
Quikchange ® (Stratagene, La Jolla, CA) strategy using pDE19 as the template and the 
following primer pairs to introduce the appropriate mutations: 
E27Lf 5’ GACATTAGTCTTGGAACTCTGAGCGGAAAAACAAAACTGC 3’ & 
E27Lr 5’ CCTCCTTCTTCGGCTAGATAAACACGCAGTTTTGTTTTTC 3’; D208Rf 
5’ CTGGGTGGAATCATCTCGTAACGATGAACACTATGACCCG 3’ & D208Rr 5’ 
GTTACGAGATGATTCCACCCAGCCGCTGTATTTAAATGTG 3’; S223Gf 5’ 
GGAAAAAGAATCACTTATCGCGGTAAGGTCAAAGACCAAAAT 3’ & S223Gr 5’ 
CATTGACTGCAACAGAATAGTAATTTTGGTCTTTGACCTTACCG 3’. 
 
Determination of the relative substrate specificities: 30 μM of the appropriate 
substrate was incubated with 1-20 nM enzyme for 45min such that the enzyme cleaved 
the preferred substrate 40-50%. Reaction conditions were optimized for each enzyme-
substrate pair and the percentage cleavage was estimated on the HPLC. The relative 




Human-β-defensin 3 assays: E. coli viability assays were performed using the liquid 
microdilution assays in salt-free buffers (17). Briefly, cells were grown to an OD600 of 2 
units in 2xYT; 0.5 ml cells spun down at 10 krpm for 2 min, washed and resuspended in 
0.5 ml 10m M Na2HPO4, pH = 7.4.  9μl of cells (~107 cells) were mixed with 1 μl of 
human-β-defenesin3 (final concentration 40ug/ml) or 1 μl water (control) and incubated 
at 37oC for 4 h. The cells were then recovered by the addition of 990 μl of LB and serial 
dilutions plated to estimate cell viability. The reported percentages are the number of 
cells surviving in the presence of the defensin to the corresponding ratio of cells 
incubated with water as a control. Human-β-defensin3 (~90% pure) was purchased from 
AnaSpec (San Jose, CA). 
 
3.3 Results 
3.3.1 Engineering the P1 specificity of OmpT 
Modification of the selection substrate:  The FRET selection substrate described in 
Chapter 2 for the two-color selection/counter-selection flow-cytometric assay used 
tetramethylrhodamine (TMR, red) to quench BODIPY (BD, green) fluorescence. 
Substrate cleavage results in release of the TMR quencher, and the captured cleavage 
product labels the cell with green fluorescence. Since the intact FRET selection substrate 
has an overall positive charge, it is anchored on the negatively charged E. coli surface 
and cells not expressing OmpT should be decorated with the uncleaved FRET substrate. 
However, since TMR quenches the BD fluorescence, and the quenching causes excitation 
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and subsequent fluorescence of TMR, cells not expressing OmpT have a red (TMR) 
fluorescent profile. This is not a problem with cells that do not express OmpT or cells 
that express inactive OmpT variants, as these will show up as red fluorescent cells and 
will not be selected. Selection of moderate activity (cells expressing enzyme that cleave 
only a fraction of the FRET substrate anchored on the surface) but specific OmpT 
variants expressed on the surface cannot be achieved using the current assay. Since the 
enzyme is able to turnover only part of the FRET selection substrate, these cells will be 
decorated with a combination of the fluorescent BD fragment (green fluorescence) and 
the uncleaved substrate (red fluorescence). The fluorescence profile of these cells is thus 
both green and red, the same as non-specific enzymes. The ability to monitor 
fluorescence and hence reactivity with the WT counter-selection substrate labeled with 
TMR is thus lost (Figure 3.1). 
 
In order to overcome this limitation, we explored the use of a non-fluorescent quencher. 
QSY7 (Invitrogen, Carlsbad, CA), a dark quencher, has spectral properties ideally suited 
for overlap with BD. Conjugation of QSY7 –C5-maleimide to the cystiene on the 
Ala↓Arg selection peptide under basic conditions (0.5 M NaHCO3) yielded the 
conjugate, AR-Q7. Following FPLC purification, AR-Q7 was conjugated to BODIPY-
FL-SE (Invitrogen, Carlsbad, CA) using the lysine ε-amine on the peptide under mildly 
basic conditions (10mM Na2HPO4, pH = 7.4) to yield AR-BQ7. The product was FPLC 
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purified using a reverse-phase column and product identity confirmed using mass-
spectrometry.  
 
Cells expressing no enzyme, E. coli BL21(DE3) [ompP ompT]; WT OmpT; and 
OmpTS223R (a highly active Ala↓Arg  enzyme, Chapter 2) were grown up in 2ml 
cultures with ampicillin to an OD600 of 2 units at 37oC. 1 ml of each culture was washed 
with 1%  sucrose to get rid of the salts and resuspended in 1 ml 1% sucrose. An aliquot of 
the cells were then labeled with either 20 nM AR-FR (Fluorophore = BD/ Quencher = 
TMR) or 20 nM AR-BQ7 (Fluorophore = BD/ Quencher = QSY7) and analyzed by flow-
cytometry. All three populations showed similar profiles with both probes (not shown), 
indicating no significant differences between TMR and QSY7 as the quenching partner in 


















































































































In order to evolve a set of highly active OmpT endopeptidases that have P1 specificities 
altered systematically to recognize one amino acid from each of the six classes of amino 
acids (Table 3.1) (18), a set of random mutagenesis and multiple residue saturation 
libraries were constructed using error-prone PCR and primer based assembly mutagenesis 
(Table 3.2).  
 
 
Amino acid Property Targets for OmpT evolution 
  P1 P1’ 
    
Arginine Basic Arg-Arg (WT) Arg-Val 
Alanine Hydrophobic Ala-Arg  
Glutamic Acid Acidic Glu-Arg Glu-Ala 
Tyrosine Aromatic Tyr-Arg  
Threonine Polar Thr-Arg  
Proline Folding Pro-Arg  
    
` 










Library Size Mutagenesis 
   
1ePCR 2 x108 Error-prone : 1.0% 
3ePCR 1 x108 Error-prone : 3.0% 
50% NNS 2 x108 NNS : 21 residues, 50% randomized primer *
90% NNS 3 x108 NNS : 21 residues, 90% randomized primer *
Sat3 1 x106 Saturation : 27,208, 223 
Sat7 6 x108 NNS : 27,29,39,40,42,208 & 223 
Sat3eP 2 x108 Error-prone 1% on Sat3 plasmid 
   
 
 
Library Size Mutagenesis Parent 
    
ER3ePCR 1 x108 Error-prone 1% StER3 
ER3Sat3 2 x106 Saturation: 89,97,150 StER3 
TRePCR 2 x108 Error-prone 0.8% StTR2 
PR5ePCR 3 x108 Error-prone 0.8% 90PR3 
S223DePCR 2 x108 Error-prone 0.6% S223D 
    
 
Table 3.2: The set of libraries used for the engineering of OmpT substrate specificity.  
The assembly reaction was carried out using a primer mixture with either a 1:1 or 9:1 
ratio of randomized primer to the wild-type (WT) primer. For more details on the PCR 
assembly reactions please refer to Materials and Methods. 
 
 
Engineering of Glu↓Arg activity: In Chapter 2 we reported the evolution of an OmpT 
variant that efficiently cleaved an Ala-Arg substrate but not the WT Arg-Arg 
 103
subtrate(15).  We then attempted to isolate an enzyme variant that would selectively 
recognize a Glu↓Arg substrate while displaying no WT (Arg-Arg) activity. An error-
prone library, 1ePCR (Table 3.2), was constructed by mutagenic PCR based on the ompT 
gene as template. The entire library was cloned into pDUCE19 (pUC19 based vector 
designed to express OmpT under the control of its native promoter). The ligation mixture 
was transformed into electrocompetent E. coli MC1061 to yield 2x108 independent 
transformants. Plasmid was pooled and retransformed into the selection strain, E. coli 
BL21(DE3), which is an ompT ompP deficient strain. The cells were grown for 6-8 h at 
37oC until they reached an OD600 of 2 units. A 1 ml aliquot of the culture (~109 cells) was 
washed and resuspended in 1% sucrose to get rid of salts and labeled with 20 nM 
Glu↓Arg and 100 nM Arg↓Arg, then sorted on the MoFlo (Dako, Fort Collins, CO) 
(Figure 3.2) flow-cytometer.  Unfortunately, after five rounds of sorting, no enrichment 






















































































































































































































































































































































































































The lack of success in isolating variants with altered Glu↓Arg specificity was not 
surprising given the fact that electrostatic reversal of ion-pair specificity had been 
attempted in multiple proteins including trypsin with very little or no success (19, 20). In 
fact the ion-pair reversal by protein engineering had been deemed unlikely in the 
literature because of completely different dielectric constants for the two different 
microenvironments (21). To circumvent this problem, a complete remodeling of the S1 
subsite was required to change the microenvironment around the charge. Accordingly, a 
saturation mutagenesis library of the three residues (Glu27, Asp208, Ser223) that 
constitute the bottom of the S1 binding site of OmpT was constructed using assembly 
PCR. The PCR product was similarly cloned and transformed into electrocompetent E. 
coli BL21(DE3) to yield 1x106 independent transformants. The E. coli OmpT library was 
washed and resuspended in 1% sucrose and labeled with 20 nM Glu↓Arg selection 
substrate and 100 nM Arg↓Arg counter-selection substrate (Figure 3.2). Cells expressing 
high BODPIY fluorescence (green, FL-1, 530/40 emission) and low TMR fluorescence 
(red, FL-2, 570/40 emission) were sorted into 3 ml of 2xYT on the MoFlo flow-
cytometer. The cells were grown to an OD600 of 2 units at 37oC, labeled and sorted again. 
After four rounds of sorting (Figure 3.3), no further increase in the mean fluorescence 
was observed, and the sorted cells were plated onto selective agar plates. Single colonies 
were picked and their fluorescence profile analyzed separately using the selection and 


























 FL-1 Fluorescence 
 
Figure 3.3: Single-color fluorescence profile of the E. coli OmpT Sat3 library though 
multiple rounds of sorting using the Glu↓Arg substrate. 
 
Five clones that showed high FL-1 fluorescence and low FL-2 fluorescence (Figure 3.4), 
consistent with the sorting criteria, were sequenced. DNA sequencing of the gene that 
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encodes the high-fluorescence variants indicated that all five clones were the same OmpT 




A. BL21(DE3):ER-BQ7 20nM 






E. StER3 RRH-TMR 100nM 
Figure 3.4: Fluorescence histograms of (A&B) BL21(DE3), (C) wild type OmpT and 
(D&E) StER3 with the Glu↓Arg (selection) and Arg↓Arg (counter-selection) substrates. 
Briefly, cells corresponding to an OD of 2 were spun down, washed and resuspended in 
1% sucrose. 50 μl cells diluted to 1 ml in 1% sucrose were labeled with the indicated 
substrate and an aliquot of the labeling reaction analyzed on the flow-cytometer. 
 
Residue number Enzyme 
27 208 223 
OmpT Glu Asp Ser 
StER3 Leu Arg Gly 
 
Table 3.3: List of amino acid changes in the Glu↓Arg variant, StER3, relative to OmpT. 
Acidic residues are colored red and basic residues colored blue. 
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Interestingly, an inspection of the amino acid changes in StER3 (Table 3.3) showed that 
the polarity of the S1 subsite had been switched from acidic to basic. The electrostatic 
potential surface of the StER3 variant, modeled on the crystal structure of OmpT (14), is 
indicative of the reversal of polarity (change from red to blue color) at the bottom of the 




























Figure 3.5: The electrostatic potential surfaces of (A) wild type OmpT and (B) StER3 
variant rendered using WebLab ViewerLite (Accelrys, San Diego, CA). The green box 
indicates the putative S1 subsite. Red indicates regions of negative charge, blue indicates 
regions of positive charge and white patches represent hydrophobic segments.  
 
 
In order to test if the altered specificity of the StER3 variant was indeed due to the 
remodeling of the S1 subsite, the three point mutants were constructed using the 
QuikChange protocol. Flow-cyometric evaluation of the Glu↓Arg activities of each of the 
point mutants demonstrated that none of them had any appreciable level of Glu↓Arg 




A. E27L ER-BQ7 20nM  B. E27L RRH-TMR 100nM  
 
 
C. D208R ER-BQ7 20nM  D. D208R RRH-TMR 100nM  
 
 
E. S223G ER-BQ7 20nM  F. S223G RRH-TMR 100nM  
 
Figure 3.6: Fluorescence histograms of the three point mutants, (A&B) Glu27Val, 
(C&D) Asp208Arg and (E&F) Ser223Gly.  
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The protein was extracted from the membranes using n-octyl glucoside and purified 
(>90% as estimated by SDS-PAGE) (15) . In order to estimate the kinetic parameters, kcat 
and KM, 10-30 μM of the HPLC substrate, WCERVGKGRGR (Figure 3.1B), was 
incubated with 10 nM purified enzyme at 250C for 10 minutes and product formation was 
analyzed by monitoring tryptophan absorbance at 280 nm. The initial rates determined at 
a series of substrate concentrations (10-30 μM) were then fitted to a Michelis-Menten 
equation using non-linear regression algorithms. Kinetic analysis of StER3 confirmed 
that the selection yielded the expected outcome i.e. the engineering of a highly specific 
enzyme (Table 3.3). Additionally, the kcat/KM, of the protein with its preferred substrate, 
Glu↓Arg , was on par with the activity of OmpT with its preferred substrate, Arg↓Arg.  
 
 
Enzyme -Glu↓Arg-1 -Arg↓Arg-2 Specificity 
 kcat/KM (M-1S-1) kcat/KM(M-1S-1) -GluArg-/-Arg-Arg- 
OmpT ----* 2±1 x104 ------ 
StER3 3±2 x105 20±10 1.5 x104
 
Table 3.4: Kinetic parameters for the hydrolysis of unlabelled selection and counter-
selection substrates by OmpT and StER3. Reactions were carried out at room temperature 
(25oC). * No cleavage observed after a 24 h incubation of 30 μM substrate with 100 nM 
enzyme 
1 Substrate sequence WCERVGKGRGR 
2 Substrate sequence WEEGGRRVGKGR 
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Engineering of Tyr↓Arg activity:  Having been successful in the isolation of the 
Glu↓Arg variant, StER3, the next target for the engineering of OmpT specificity, 
Tyr↓Arg, was chosen. The conversion of the P1 specificity of OmpT from Arg to Tyr is 
analogous to the conversion of the P1 specificity of trypsin to chymotrypsin (22). 
Screening of the Sat3 library, saturation at residues Glu27, Asp208 and Ser223, with 
Tyr↓Arg as the selection substrate and Arg↓Arg as the counter-selection substrate 
yielded no clones displaying an altered fluorescence profile.  In order to design a more 
comprehensive library, all of the active-site residues potentially important for peptide 
binding/catalysis were first identified using a model of the OmpT crystal structure (14).  
Since Asp83, Asp85, Asp210 and His212 are believed to be critical for catalysis (14), 
these were excluded. The remaining 21 residues that constitute potential peptide 
binding/recognition sites were targeted for randomization. A library, 90NNS, was 
constructed by mixing randomized NNS primers with the primers for the wild-type 
codon, across these 21 residues (the actual residues are listed in the Materials and 
Methods section) in the assembly PCR reaction (Table 3.2) . The PCR fragment was re-
amplified to enrich full length genes, gel-puirifed, digested and ligated into pDMLE19. 
The ligation was desalted and transformed into electrocompetent E. coli MC1061 and 
plated on selective media to yield 3x108 transformants. DNA sequencing of 10 random 
clones from this library indicated that an average of 10 out of the 21 residues targeted 
were mutated in any given gene. The plasmid library isolated from these cells was 
retransformed into electrocompetent E. coli BL21(DE3); the cells grown up to an OD600 
 114
of 2 units in selective media, washed with 1% sucrose and labeled with 20 nM Tyr↓Arg 
and 100 nM Arg↓Arg substrates. Flow-cytometric sorting was accomplished by setting 
gates based on FSC/SSC and FL1/FL2 profiles to enrich for cells expressing a Tyr↓Arg 
specific OmpT variant. After six rounds of sorting/resorting, the mean of the population 
remained constant. Five colonies from the final round of sorting were picked at random, 
grown up individually, labeled using the Tyr↓Arg and Arg↓Arg substrates, and their 
fluorescence profiles assayed by flow-cytometry. All five clones exhibited similar 
profiles in line with the screening criteria (Figure 3.7) and DNA sequencing revealed that 
all five clones encoded the same OmpT variant, 90YR3 (Table 3.4).  
 
 
F. 90YR3 YR-BQ7 20nM  G. 90YR3 RRH-TMR 100nM 
 
Figure 3.7: Fluorescence histograms of the 90YR3 variant labeled with the YR-BQ7 and 
RRH-TMR substrates.  
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Enzyme Residue number 
 27 29 170 172 208 221 265 
OmpT Glu Val Ile Tyr Asp Tyr Leu 
90YR3 Trp Pro Val Val His Ala Val 
        
 
Table 3.5: List of amino acid changes in 90YR3 relative to OmpT. 
 
Inspection of the amino acid changes in 90YR3 relative to OmpT indicated that aromatic 
residues had replaced the acidic residues at the bottom of the negatively charged S1 
subsite (Glu27Trp & Asp208His). Since the Sat3 presumably library included these two 
residues, it is clear that although these residues are important for the altered specificity of 
90YR3, they are not sufficient. An examination of the potential surface of 90YR3 in 
comparison to WT OmpT indicated an enlarged S1 subsite, which would be expected to 










Figure 3.8:  The potential surface of (A) OmpT & (B) 90YR3 generated using WebLab 
ViewerLite (Accelrys, San Diego, CA). The boxed region indicates the S1 subsite. 
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 To estimate the kinetic parameters, kcat and KM, the enzyme was purified (>90% as 
estimated by SDS-PAGE) by extraction with n-octyl glucoside. Initial rates were 
determined by incubating 5 nMpurified enzyme with 10-30 μM HPLC substrate, 
WCYRVGKGRGR, in a 100 μl reaction at 25oC for 15 minutes, and the initial rates were 
fitted to a Michaelis-Menten equation. The catalytic efficiency of 90YR3, kcat/KM with 
the Tyr↓Arg HPLC substrate was estimated as 8±3x104, similar to the efficiency of 
OmpT with its preferred dibasic substrate. Additionally, the 90YR3 variant showed no 
cross-reactivity with the WT Arg-Arg substrate.  
 
Engineering of Thr↓Arg activity: Initial attempts to isolate a highly active Thr↓Arg 
variant, based on screening the three residue saturation mutagenesis library, Sat3; the 
OmpT error-prone library, 1ePCR; and the 21-residue randomization library, 90NNS  
were unsuccessful.  A focused library, which would allow a more complete radomization 
at fewer residues was sought. Accordingly, the seven residues that make up the S1 
subsite, were identified based on the crystal structure of OmpT. A new library, designated 
Sat7 (Table 3.2), was constructed by using NNS primers encoding for these amino acids; 
27,29,39,40,42, 208 and 223. Purification, digestion, ligation and subsequent 
transformation into E. coli MC1061 yielded 6x108 independent transformants. Following 
plasmid isolation, re-transformation, growth and subsequent labeling, as above, a total of 
2x107 cells were analyzed on the MoFlo flow-cytometer with sorting gates set to collect 
1% of cells displaying high FL-1 fluorescence (high activity with TR-BQ7) and low FL-2 
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fluorescence (low activity with RRH-TMR). Four rounds of sorting led to the isolation of 
the StTR2 variant. Fluorescence profiles of the StTR2 variant indicated that the enzyme 
was selective, but the overall fluorescence with the FACS selection substrate, Thr↓Arg 
indicated that the enzyme was unlikely to posses a high level of activity (Figure 3.9). 
Consistent with the flow-cytometric data, HPLC analysis of the cleavage of the Thr↓Arg 
substrate using purified enzyme (30-50 nM) showed very little cleavage (<10%) even 
after prolonged incubation (3 h).  
 
 







Figure 3.9: Fluorescence histograms of cells expressing the StTR2 variant labeled with 
the Thr↓Arg and Arg↓Arg FACS substrates.  
 
In order to engineer an enzyme exhibiting more efficient Thr↓Arg hydrolysis, which in 
turn would result in higher fluorescence with the selection substrate, TR-BQ7 , the gene 
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encoding for StTR2 was subjected to random mutagenesis using error-prone PCR (Table 
3.2). The resulting library was digested, ligated, and transformed into electrocompetent E. 
coli MC1061 cells to yield 2 x 108 independent transformants. DNA sequencing of 10 
random clones from the library indicated an average of 8 substitutions per gene (0.8%).   
Library plasmid was pooled from transformed cells scraped from plates and grown for 5 
generations.  The pooled plasmids were re-transformed into E. coli BL21(DE3) ; the cells 
grown  to an OD600 of 2 units, labeled using 20 nM Thr↓Arg and 100 nM Arg↓Arg and 
sorted. After three rounds of sorting, cells were sorted onto selective agar plates and 
grown at 37oC overnight. Six clones were picked at random and their fluorescence 
profiles analyzed by flow-cytometry. All six clones showed high fluorescence when 
labeled with the TR-BQ7 substrate and low fluorescence when labeled with the RRH-
TMR substrate (Figure 3.10). Sequencing revealed that all six clones encoded the same 





      
A. eTR2 TR-BQ7 20nM  B. eTR2 RRH-TMR 100nM  
Figure 3.10: Fluorescence histograms of the eTR2 variant labeled with the TR-BQ7 
(selection) and RRH-TMR (counter-selection) substrates. 
 
A comparison of the amino acid sequences of both the StTR2 and eTR2 variants showed 
that they had four and nine changes, respectively, relative to WT OmpT (Table 3.6).  
Although seven amino acids (27,29,29,40,42,208,223) were targeted for randomization in 
the parent Sat7 library, the StTR2 variant had only four mutations; Glu27His, Val29Ser, 
Asp208Leu and Ser223Asp. The Val29Ser change at the entrance of the S1 subsite, can 
potentially hydrogen bond to the threonine in the substrate facilitating recognition. It is 






Residue number Enzyme 
 27 29 208 214 223 243 253 270 276 
OmpT Glu Val Asp Asp Ser Pro Trp Asn Ser 
StTR2 His Ser Leu Asp Asp Pro Trp Asn Ser 
eTR2 His Ser Leu Asn Asp Ser Gly Tyr Gly 
          
 
Table 3.6: List of mutations in StTR2 and eTR2, relative to OmpT. The mutations in 
eTR2 derived from StTR2 (parent) are italicized.  
 
 The kinetic parameters for the hydrolysis of Thr↓Arg HPLC substrate were determined 
by incubating 15 nM of the purified enzyme (>80% pure SDS-PAGE) with 10-30 μM 
HPLC peptide, WCTRVGKGRGR, at 25oC for 30 minutes. It is noteworthy that the 
catalytic efficiency, kcat/KM, of the eTR2 substrate (2±1 *104 M-1S-1) with its preferred 
substrate, Thr↓Arg was almost the same as that of OmpT with its preferred substrate 
containing an Arg↓Arg cleavage site. As always, mass spectrometry (LC-MS ESI 
analysis) was used to assign the cleavage site. 
 
Engineering of Pro↓Arg activity: Despite screening four different libraries; the three 
residue saturation mutagenesis library, Sat3; the OmpT error-prone library, 1ePCR; the 
seven residue NNS library, Sat7, and the 21-residue randomization library, 90NNS,    
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using dual-color selection/counter-selection assays, OmpT variants that would selectively 
hydrolyze a Pro↓Arg substrate could not be isolated. The best enzyme, 90PR3, isolated 
by screening a 90NNS library, showed a moderate increase in fluorescence (Figure 3.11) 
compared to background (8-10 fold increase in fluorescence).   Because the fluorescence 
of this variant labeled with the PR-BQ7 substrate was not indicative of a high activity 
clone, further characterization was not performed.  In an attempt to isolate a variant 
capable of efficiently hydrolyzing Pro↓Arg sequences, an error-prone library was 
constructed based on the 90PR3 variant as the template. Gel-purification, restriction 
digestion, ligation into pDMLE19 and subsequent transformation into electrocompetent 
E. coli MC1061 yielded 3x108 transformants. Sequencing revealed an average of 8 
nucleotide changes per gene (0.8%). The plasmid library isolated from the pooled, 
scraped cells was retransformed into E. coli BL21(DE3) and the cells grown to an OD600 
of 2 units. The cells were washed with 1% sucrose and an aliquot of the cells labeled 
using 20 nM Pro↓Arg and 100 nM Arg↓Arg. After the 10 minute incubation, 2.6x107 
cells were analyzed on the flow-cytometer and 1.2% of the total population was collected 
based on high FL-1 fluorescence and low FL-2 fluorescence. After four rounds of sorting, 
no enrichment was observed and hence no further sorting was done. 
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A. 90PR3 PR-BQ7 20nM  B. 90PR3 RRH-TMR 100nM 
Figure 3.11: Fluorescence histograms of 90PR3 labeled with PR-BQ7 (selection 
substrate) and RRH-TMR (counter-selection substrate).   
 Sequencing of the genes encode by 90PR3 revealed that it had nine amino acid changes 
relative to OmpT. However, (Table 3.7) upon further analysis the enzyme was found not 
to be very specific and therefore was not further characterized.   
 
Enzyme Residue number 
 81 97 150 163 170 208 221 265 282 
OmpT Met Asp Tyr Phe Ile Asp Tyr Leu Ile 
90PR3 Glu Ser His Phe Asp Leu Leu Thr Met 
 
Table 3.7: List of amino acid changes in 90PR3 relative to OmpT.  
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Substrate selectivity of the engineered OmpT variants: As discussed above, enzyme 
kinetics analysis with peptide containing either the selection or the counterselection 
peptide revealed that the engineered OmpT variants were highly selective. We then 
examined whether the isolated enzyme variants could cleave sequences other than the 
selection  peptide.  Initial conditions for cleavage were determined using 1-20 nM 
purified enzymes with 30μM selection substrate such that the enzyme cleaved 40-50% of 
the selection substrate in 45 minutes. After having determined the optimal initial 
conditions, the enzyme concentration was set and the percentage cleavage determined for 
a panel of 6 substrates that have the P1 amino acid systematically changed to include one 
amino acid from the six classes of amino acids (Table 3.12) (18).  WT OmpT prefers the 
dibasic peptide and shows a weak activity for cleavage at Ala↓Arg (80-fold lower 
kcat/KM, see chapter 2), but failed to cleave any of the other peptides at Xaa↓Arg (There 
were secondary cleavage sites on the peptides, please see table 3.12). The OmpTS223Arg 
mutant and StER3 show no cross-reactivity with any of the other substrates, indicating 
that they were remarkably specific enzymes. 90YR3, the enzyme selected for high 
activity towards Tyr↓Arg, shows a weak cross-reactivity for cleavage at Ala↓Arg 
sequences but is otherwise specific.  The eTR2 variant shows cross-reactivity for 
cleavage at Glu↓Arg sequences and weak activity for cleavage at Ala↓Arg but it 
preferentially cleaves Thr↓Arg sequences, consistent with its selection criterion.  The 
systematic analysis of the P1 specificity of these variants demonstrates that these 







Relative substrate preferences kcat/KM
(M-1s-1) 
  R↓R1 A↓R2 E↓R2 Y↓R2 T↓R2 P↓R2  
         
WTOmpT - 1 0.04 - -# -* -* 2±1 x 104 &
S223R 1 - 1 - - - - 2.6±0.8 x105
StER3 3 - - 1 - - - 3±2 x105
90YR3 7 - 0.2 - 1 - - 8±3 x104
eTR2 9 - 0.05 0.3 - 1 - 2±1 x 104
         
         
         
Table 3.8: Kinetic characterization and the relative substrate preferences of wild type 
OmpT and the OmpT variants measured at room temperature (25oC). A dash (-) indicates 
that no substrate cleavage was observed under the conditions. 
 
1 Substrate sequence: WEEGGRRVGKGR 
2 Substrate sequence: WCXRVGKGRGR where X = A/E/Y/T/P 
# OmpT cleaves the peptide between R↓V 
* OmpT cleaves the peptide between K↓G 
& OmpT cleaves the peptide sequence WEEGGR↓RIGRGGK with kcat/KM of 




3.3.2 Engineering the P1’ specificity of OmpT 
 Having successfully remodeled the S1 substrate binding pocket to recognize a 
diverse set of amino acids, the next step was to explore changing the selectivity for the 
S1’ subsite.  
Engineering of Arg↓Val activity: Olsen et al. had previously reported the engineering 
of an OmpT variant C5 that showed a 60- fold improvement towards the hydrolysis of 
Arg↓Val substrates (23) compared to WT OmpT. That enzyme, however, turned out to 
be non-specific and cleaved the peptide sequence, WGGPGRVVGGTI, at multiple sites.  
OmpT showed weak activity for cleavage at Arg↓Val with the Tyr-Arg-Val substrate 
(Table 3.12). The Tyr-Arg-Val substrate was used as the selection substrate in an attempt 
to engineer a selective Arg↓Val variant. Also, the counter-selection substrate has the 
Arg-Arg-Val sequence (Figure 3.2) and counter-selection using this substrate while 
selecting with the Tyr-Arg-Val substrate would facilitate isolation of variants that cleave 
Tyr↓Arg-Val sequences and not Arg↓Val sequences. Hence, library screening was 
performed using selection-only assays.  
The plasmid library isolated from the three residue saturation library, Sat3, was freshly 
transformed into electrocompetent E. coli BL21(DE3) and grown up to an OD600 of 2 
units. The cells were washed and resuspended in 1% sucrose and labeled with 20 nM 
Tyr-Arg↓Val substrate. After a ten-minute incubation, the library was sorted on the 
MoFlo and gates were set to collect 1% of the most fluorescent cells. Following four 
 127
rounds of sorting, the cells were sorted onto LB/ampicillin (200μg/ml) plates. Five 
randomly selected clones when assayed on the flow-cytometer showed identical 
fluorescence profiles (Figure 3.12). Surprisingly, although three residues were targeted 
for randomization, the best variant, encoded by all five clones, had only one amino acid 
change, OmpTSer223Asp. Not surprisingly, the OmpTSer223Asp mutation increases the 
overall negative charge in concert with the other two WT residues, Glu27 and Asp208 
and may help better recognize the P1 arginine on the substrate. Initial kinetic 
characterization using 50 nM purified enzyme and 30 μM substrate indicated that this 
was not a high activity enzyme and hence further characterization was not performed. 
 
 








Figure 3.12: Fluorescence histogram of the OmpTSer223Asp variant labeled with the 
Tyr-Arg↓Val substrate. 
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To engineer a variant that showed high activity towards the hydrolysis of Arg↓Val 
sequences, an error-prone library was constructed using ompTSer223Asp gene as the 
template in mutagenic PCR. The resulting library, S223DePCR, was gel-purified, 
restriction enzyme digested, ligated into pDUCE19 and transformed into 
electrocompetent E. coli MC1061 to yield 2x108 transformants. The plasmid library was 
isolated from pooled, scraped cells; retransformed into E. coli BL21(DE3) and grown up 
in 1 l of 2xYT containing 200 μg/ml to an OD600 of 2 units. The cells were washed with 
1% sucrose and labeled with 20 nM of Tyr-Arg↓Val substrate and analyzed on the flow-
cytometer. Not surprisingly, the majority of the clones displayed a fluorescence profile 
similar to OmpTSer223Asp. The top 1% fluorescent cells were sorted into 2xYT, grown 
up, labeled, and resorted. After three rounds of sorting, the cells were sorted onto 
LB/ampicllin plates. Cells expressing the consensus variant, eRV6, showed bright green 
fluorescence, indicating the presence of a highly active enzyme (Figure 3.13). 
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eRV6 YRV-BQ7 20nM  
Figure 3.13: Fluorescence histogram of the eRV6 variant labeled with the Tyr-Arg↓Val 
substrate. 
 
Sequencing of the gene indicated that it contained 2 nucleotide changes resulting in two 
amino acid substitutions; Gln63Arg and Asp97His.  In addition, it contained the 
Ser223Asp substitution found in the parent clone used as the template for error-prone 
PCR (Table 3.9). The kinetic parameters for the hydrolysis of Arg↓Val HPLC substrate 
were determined by incubating 1 nM of the purified enzyme (>90% pure SDS-PAGE) 
with 10-30 μM HPLC peptide, WCYRVGKGRGR, at 25oC for 10 minutes. Kinetic 
analysis of the eRV6 variant confirmed that the enzyme was highly active with a kcat/KM 
of 5±2 x105 M-1s-1 and mass spectrometry was used to assign the cleavage between 




Residue number Enzyme 
63 97 223 
OmpT Gln Asp Ser 
eRV6 Arg His Asp 
 













































Plasminogen activation assay: The site-specific activation of plasminogen to plasmin 
occurs by cleavage between Arg561↓Val562. In order to investigate the ability of the 
engineered OmpT Arg↓Val mutant, eRV6, to activate plasminogen, the enzyme was 
purified and incubated with human-Glu-type plasminogen.  Plasmin formation analyzed 
by virtue of its ability to hydrolyze a chromogenic substrate in a coupled assay (24). The 
direct hydrolysis of the chromogenic substrate by eRV6 in the absence of plasminogen 
was employed as a negative control, to rule out any unwanted activity towards the 
chromogenic substrate. The OmpT mutant, eRV6, showed a concentration dependant 
activation of plasminogen to plasmin (Figure 3.14) and showed no increase in absorbance 
in the absence of plasminogen (not shown). OmpT, consistent with earlier reports (25), 











































Figure 3.15: Concentration dependant activation of plasminogen by (A) purified tPA and 
(B) eRV6 & OmpT 
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Engineering of Glu↓Ala activity: As mentioned before, WT OmpT preferentially 
cleaves at dibasic residues (Arg preferred in both P1 and P1’). Having successfully 
demonstrated the engineering of OmpT to accept diverse substrates in S1, the ability to 
isolate OmpT variants that selectively hydrolyzed unrelated, non-preferred sequences like 
Glu-Ala was explored. The DNA encoding the Glu↓Arg mutant, StER3, was used as a 
template to construct two different libraries; the first library involved saturation 
mutagenesis of residues 87, 97 and 150; and the second library was constructed by error-
prone PCR (Table 3.2). Again, following cloning and transformation into 
electrocompetent E. coli MC1061, the error-prone library, ER3ePCR yielded 1x108 
transformants. Sequencing ten random clones revealed that the average mutation rate was 
8 nucleotides per gene (0.8%). Since a much smaller library was sufficient to cover the 
diversity of the three-residue saturation library, the ligation was directly transformed into 
electrocompetent E. coli BL21(DE3). The two libraries, ER3PCR and ER3Sat3, were 
grown up to an OD600 of 2 units in 1 l of 2xYT containing 200 μg/ml ampicillin at 37oC. 
The cells were washed with 1% sucrose and labeled with 20 nM Glu↓Arg for ten 
minutes. An aliquot of the labeling reactions were analyzed on the flow-cytometer and 
gates set based on FSC/SSC and FL-1 to sort 0.9% - 1.1% of the most fluorescent cells.  
After four rounds of sorting, no enrichment was observed with the ER3Sat3 library. On 
the other hand, the ER3ePCR library after five rounds of sorting showed promising 
enrichment and cells were sorted onto selective plates. Five clones picked at random 
showed similar fluorescence profiles when assayed by flow-cytometry (Figure 3.15).   
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Figure 3.16: Fluorescence histograms of (A) StER3 & (B) eEA4 labeled with the 
Glu↓Ala substrate. 
 
Sequencing of the gene encoding the five different clones led to the identification of the 
consensus eEA4 variant that had seven additional changes compared to StER3, the 








Enzyme Residue number 
 27 48 183 208 214 216 223 244 274 280 
OmpT Glu Asn Leu Asp Asp Gly Ser Asn Asp Ala 
StER3 Leu Asn Leu Arg Asp Gly Gly Asn Asp Ala 
eEA4 Leu Asp Phe Arg Asn Glu Gly Ile Gly Glu 
 
Table 3.10: Amino acid changes in eEA4 relative to OmpT & StER3. The changes 
common to StER3 and eEA4 are italicized. 
 
In order to determine the kinetic parameters of the eEA4 variant towards hydrolysis of 
the Glu↓Ala substrate, 6-20 μM of the HPLC substrate, WCEAVGKGRGR, was 
incubated with 1 nM purified enzyme (>90% as estimated by SDS-PAGE) at 25oC for 
10min. The measured catalytic efficiency, kcat/KM, of the eEA4 variant was 1±0.3x106, 
better than the efficiency of OmpT with its preferred Arg-Arg substrate, 2±1x104. 
Cleavage at Glu↓Ala by the eEA4 variant was confirmed using mass-spectrometry.   
 
3.3.3 Human-β-defensin3 assays:  The systematic engineering of substrate specificity 
demonstrated that OmpT is a surprisingly plastic enzyme, capable of adapting to a wide 
variety of new substrates. The ability of OmpT to cleave highly cationic antimicrobial 
peptides has been reported before (26). The co-evolution of cationic antimicrobial 
defense peptides and the counter resistance mechanisms in bacteria represents a fine 
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example of symbiotic adaptive evolution (27). β-Defensins are cationic antimicrobials 
that consist of compactly folded β-sheets held together by multiple disulfide bonds that 
renders them resistant to bacterial proteolysis. In order to test the hypothesis that the 
plasticity of OmpT might contribute towards facile adaptation to cleave a changing array 
of antimicrobials, the potential cleavage sites for the engineered OmpT variants in 
human-β-defensin3 (HBD-3) were mapped out (Figure 3.16). Two potential sites within 
HBD-3 could be cleaved by mutants generated as part of this study;, Arg12↓Val13 is a 
putative substarte foreRV6 and Thr35r↓Arg36 for eTR2. The bacteriocidal effect of 
HBD-3 towards E. coli BL21(DE3) [ompT, ompP] cells expressing no enzyme; WT 
OmpT, eRV6, or eTR2 was determined using the liquid microdilution assay (17).  
Briefly, ~107 cells were incubated with 40 μg/ml HBD-3/water (control) in salt-free 
buffer at 37C for 3h and then serial dilutions were plated to estimate viability (Table 
3.11). Cells expressing OmpT showed a 33-fold higher viability compared to cells with 
no enzyme.  Importantly the cells expressing either eRV6 or eTR2 showed >2000 fold 
improvement in viability.  









Figure 3.17: Solution structures of (A) human- β-defensin3 with the three disulfide 
bridges (HBD-3, PDB ID: 1KJ6) (B) HBD-3 with Arg12 & Val13 residues highlighted & 





Cell count # % Viability 
    
BL21(DE3) - 2 x 107 < 0.006 
 40 <103  
    
BL21(DE3)-OmpT - 1.2 x 107 0.2 
 40 2 x104  
    
BL21(DE3)-eRV6 - 6 x 106 17 
 40 1 x 106  
    
BL21(DE3)-eTR2 - 6 x 106 13 
 40 8 x 105  
Table 3.11: Cell viability assays measured in presence and absence of human-β -
defensin3. Briefly, ~1* 107 cells were incubated with HBD-3 at a concentration of 40 
μg/ml in 10 mM  Na2HPO4, pH=7.4 at 37oC for 3 h and the viability as a percentage of 
the same cells incubated with water as a control is reported. # The standard error in these 
assays is ±25%. 
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Cleavage of T7 RNA polymerase and auto-proteolysis (preliminary data): The ability 
of the engineered OmpT variants to cleave folded proteins was tested using T7 RNA 
polymerase. The ability of OmpT to cleave T7 RNA polymerase (Molecular weight ~100 
kDa) between Lys172↓Arg173 has been reported before(28). 300U of T7 RNA 
polymerase was incubated with 50ng of OmpT at 37oC for 2h. The reaction was then run 
on a 8-16 % gradient Tris-glycine gel and stained using GelCodeBlue ®. Four different 
bands were observed; 80 kDa, 55k Da, 25 kDa and 20 kDa. N-terminal sequencing was 
used to assign the cleavage sites for the two larger bands; 80 kDa Lys172↓Arg173, and 
55 kDa Arg391↓Lys392. When 300 units of T7 RNA polymerase was similarly 
incubated with 50-200 ng of the OmpT variants (OmpTS223R, StER3, eTR2, eRV6, 
eEA4) at 37oC for 2 h, no cleavage was observed. 
OmpT undergoes auto-proteolysis by self-cleavage between Lys217↓Arg218. In order to 
assess the ability of the engineered OmpT variants to self-cleave, reactions were setup 
with 5 μg of OmpT/OmpT variants in 10 mM MES, 10 mM EDTA, pH = 6.1 at 37oC 
overnight. The reaction was run on a 4-20 % Tris-glycine gradient gel and stained using 
GelCodeBlue ®. WT OmpT showed two bands; 25 kDa (Ser1-Lys217) and 9 kDa (faint 
band, Arg218-Phe297). All of the engineered OmpT variants (OmpTS223R, StER3, 






We have engineered the substrate specificity of the E. coli outer membrane protease 
OmpT from large libraries screened quantitatively for activity and selectivity towards 
multiple new substrates using our novel dual-color selection and counter-selection flow-
cytometric high-throughput assay. Because OmpT is not folded and active until it reaches 
the outer membrane (13), and since the catalytic core is directed towards the external 
milieu (14), the protease does not cleave essential physiological proteins or itself, during 
in vivo overexpression.  Therefore, protease libraries with diverse specificities can be 
expressed without killing the host cell.  Additionally, OmpT has many properties 
desirable for practical applications such as high thermostability, and activity in high 
concentrations of denaturants (29) or  reducing agents such as  DTT/TCEP (OmpT does 
not contain any disulfides that could be subject to reduction by such agents). 
To enable the isolation of OmpT variants that recognize substrates with altered P1 
specificities, a set of libraries were constructed using PCR based gene assembly and 
random mutagenesis. The first target for the engineering of P1 specificity of OmpT, 
Glu↓Arg, required the electrostatic reversal of ion-pair specificity (swapping positively 
and negatively charged residues between the substrate and the substrate binding-pocket in 
the enzyme).  Protein engineering has previously been used to explore the reversal of 
charges between the substrate and the substrate binding pocket in many enzymes such as 
trypsin and aspartate aminotransferase (19, 20). However, these efforts led to non-
specific enzyme variants that were not highly active. Because the microenvironment in 
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the substrate binding pocket in the WT enzyme had likely been optimized in the context 
of the native residue/substrate, introduction of the opposite charge would completely 
change the dielectric constant of the pocket (21). For this reason, electrostatic reversal of 
ion-pair specificity was deemed undoable (21). To overcome this problem, we sought to 
remodel all the residues that comprised the bottom of the S1 binding pocket in OmpT. 
Accordingly, a saturation library, Sat3, that resulted in the randomization of Glu27, 
Asp208 and Ser223 was constructed and the high-throughput dual-color selection assay 
was used to screen for OmpT variants that could selectively recognize Glu↓Arg substrate 
(Glu in P1). Multiple rounds of sorting led to the isolation of a highly active and specific 
variant, StER3. Flow cytometric analysis and in vitro kinetic characterization confirmed 
the alteration of specificity of StER3 towards Glu↓Arg substrates. Additionally, the 
purified StER3 variant showed extremely high activity with its preferred Glu↓Arg 
substrate, comparable to that of OmpT with its preferred dibasic substrate, Arg↓Arg. 
Construction and subsequent flow-cytometric analysis of the three individual point 
mutations that constitute StER3, suggested that these mutations are epistatic with respect 
to conferring Glu↓Arg activity, that is they work in a synergistic fashion that is not 
simply additive. 
Engineering the conversion of OmpT to recognize tyrosine in P1 is directly analogous to 
the conversion of the P1 specificity of trypsin to chymotrypsin (22). Chymotrypsin and 
trypsin are serine proteases that have a high degree of both sequence and structure 
homology.  Chymotrypsin cleaves after large hydrophobic residues while trypsin cleaves 
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after basic residues. In spite of this homology, conversion of trypsin into a chymotrypsin 
like protease (preference for large hydrophobic residues) by replacement of the S1 site 
residues with the corresponding ones in chymotrypsin was not successful (22). The 
conversion of trypsin to chymotrypsin was achieved by grafting entire surface loops from 
chymotrypsin (L1, L2), that were shown to be critical for amide hydrolysis rather than 
substrate recognition/binding, into trypsin.  
The construction of a semi-random mutagenesis library that targeted all of the putative 
peptide contact-residues (excluding the four residues, Asp83, Asp85, Asp210 and His212 
important for catalysis), 90NNS, and subsequent screening with the Tyr↓Arg and 
Arg↓Arg substrates, allowed the isolation of the OmpT variant 90YR3. Again, thorough 
characterization of 90YR3 demonstrated that altered specificity was not engineered at the 
cost of high overall activity. Nine amino acid changes in OmpT were sufficient to change 
it from a trypsin like protease to a chymotrypsin like protease (P1 specificity). 
Because attempts to isolate a highly active, specific Thr↓Arg variant by screening 
multiple libraries was unsuccessful; a two-step approach was used. First, a medium 
activity but specific variant, StTR2 was isolated from a Sat7 library. Next, construction of 
an error-prone library based on StTR2 and screening using Thr↓Arg & Arg↓Arg 
substrates facilitated the engineering of a highly active variant, eTR2.  
In order to truly understand the selectivity of these engineered protease variants, their 
cross-reactivity was determined across all classes of amino acids preferred/tolerated in 
P1. OmpT, consistent with earlier reports, preferred basic residues in P1 and showed no 
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cleavage after Glu/Tyr/Thr/Pro, although Ala was tolerated (13). Two enzymes, 
OmpTS223R and StER3, showed no cross-reactivity with substrates other than their 
respective selection substrates. The chymotrypsin like variant, 90YR3, showed no 
preference for substrates containing Glu/Thr/Pro/Arg in P1, although the Ala residue was 
tolerated with a lower level of activity compared to Tyr. The high activity Thr↓Arg 
variant, eTR2, showed no cleavage at Arg/Pro/Tyr, but did show appreciable cleavage 
after Glu and a weak ability to hydrolyze after Ala. However, the preferred residue was 
clearly Thr in P1, consistent with the way this enzyme was selected on the basis of high 
activity for cleavage of the Thr↓Arg substrate.  It has been previously postulated that 
“moonlighting activities” (activities not under direct selection) pop up stochastically in 
selection only environments (leading to non-specific enzymes) and that the moonlighting 
activity may confer a phenotypic advantage (30, 31). Consistent with other directed 
evolution experiments (32), the presence of an explicit negative constraint seems to 
eliminate non-specific generalist enzymes and commits the enzyme pool towards variants 
that have the desired high levels of activity and specificity  towards the selection 
substrate.  
Since the isolation of OmpT variants with altered P1 specificities was successful, the 
engineering of the P1’ specificity of OmpT was attempted. Again, a two-step approach 
was used to engineer an OmpT variant that showed high-levels of activity with Arg↓Val 
substrate. Flow-cytometry and in vitro kinetic characterization confirmed that the eRV6 
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variant was highly active for the hydrolysis at Arg↓Val sequences. The eRV6 variant, 
surprisingly, had only three mutations relative to OmpT. 
As part of the blood-clotting cascade fibrin-bound tissue plasminogen activators like tPA 
cleave plasminogen to yield a serine protease plasmin which then dissolves the cross-
linked fibrin clots into soluble fragments. The activity of plasmin is tightly regulated by 
plasmin inhibtor serpin α2-antiplasmin (α2AP). The Pla protein of Yersinia pestis is a 292 
amino acid outer membrane protease that shows about a 50% homology at the amino acid 
level to OmpT. Pla, an essential protein for the invasive character of plague (33), can 
activate plasminogen and degrade the α2AP leading to unregulated proteolysis by 
plasmin (34). The site-specific activation of plasminogen to plasmin occurs by cleavage 
between Arg561↓Val562. To investigate the ability of our engineered OmpT Arg↓Val 
mutant eRV6 to activate plasminogen, the purified enzyme was incubated with human- 
Glu-type plasminogen and plasmin formation analyzed by virtue of its ability to 
hydrolyze a chromogenic substrate. The enzyme showed a concentration dependent 
activation of plasminogen, similar to vtPA, while OmpT, consistent with earlier reports 
(25), showed only weak plasminogen activation. Interestingly, a sequence alignment of 
Pla and the eRV6 amino acid sequences indicates that the Ser223Asp mutation of eRV6 
is homologous to Glu217 of Pla (Figure 3.17). Importantly, the conversion OmpT into a 
plasminogen activator has previously been achieved through exchange of loops between 
OmpT and Pla (34). Through the application of a flow-cytometric high-throughput sassay 
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to screen large libraries, the same phenotype was isolated that required only three 
changes. 
 
OmpT -STETLS-FTPDNINADISLGTLSGKTKERVYLAEEGGRKVSQLDWKFNNAAIIKGAINW 58 
Pla  ASSQLIPNISPDSFTVAASTGMLSGKSHEMLYDAETG-RKISQLDWKIKNVAILKGDISW 59 
eRV6 -STETLS-FTPDNINADISLGTLSGKTKERVYLAEEGGRKVSQLDWKFNNAAIIKGAINW 58 
      *:: :. ::**.:..  * * ****::* :* ** * **:******::*.**:** *.* 
 
 
OmpT DLMPQISIGAAGWTTLGSRGGNMVDQDWMDSSNPGTWTDESRHPDTQLNYANEFDLNIKG 118 
Pla  DPYSFLTLNARGWTSLASGSGNMDDYDWMNE-NQSEWTDHSSHPATNVNHANEYDLNVKG 118 
eRV6 DLMPQISIGAAGWTTLGSRGGNMVDQDWMDSSNPGTWTHESRHPDTQLNYANEFDLNIKG 118 
     *  . :::.* ***:*.* .*** * ***:. * . **..* ** *::*:***:***:** 
 
OmpT WLLNEPNYRLGLMAGYQESRYSFTARGGSYIYSSEEGFRDDIGSFPNGERAIGYKQRFKM 178 
Pla  WLLQDENYKAGITAGYQETRFSWTATGGSYSYNN----GAYTGNFPKGVRVIGYNQRFSM 174 
eRV6 WLLNEPNYRLGLMAGYQESRYSFTARGGSYIYSSEEGFRDDIGSFPNGERAIGYKQRFKM 178 
     ***:: **: *: *****:*:*:** **** *..        *.**:* *.***:***.* 
 
 
OmpT PYIGLTGSYRYEDFELGGTFKYSGWVESSDNDEHYDPGKRITYRSKVKDQNYYSVAVNAG 238 
Pla  PYIGLAGQYRINDFELNALFKFSDWVRAHDNDEHY--MRDLTFREKTSGSRYYGTVINAG 232 
eRV6 PYIGLTGSYRYEDFELGGTFKYSGWVESSDNDEHYDPGKRITYRDKVKDQNYYSVAVNAG 238 




OmpT YYVTPNAKVYVEGAWNRVTNKKGNTSLYDHNN-NTSDYSKNGAGIENYNFITTAGLKYTF 297 
Pla  YYVTPNAKVFAEFTYSKYDEGKGGTQTIDKNSGDSVSIGGDAAGISNKNYTVTAGLQYRF 292 
eRV6 YYVTPNAKVYVEGAWNRVTNKKGNTSLYDHNN-NTSDYSKNGAGIENYNFITTAGLKYTF 297 
     *********:.* ::.:  : **.*.  *:*. :: . . :.***.* *: .****:* * 
 
 




In order to completely rid the ariginine requirement of OmpT in both P1 and P1’, the 
engineering of Glu↓Ala variant, starting with the Glu↓Arg enzyme, StER3, was 
attempted. The construction and screening of an error-prone library resulted in the 
isolation of a highly active Glu↓Ala variant, eEA4. The in vitro catalytic efficiency of the 
enzyme towards hydrolysis of the Glu↓Ala substrate was higher than the efficiency of 
OmpT with its preferred Arg↓Arg peptide. It is surprising that ten amino acid changes in 
the OmpT framework are enough to alter its specificity from Arg↓Arg to Glu↓Ala.  
Since the cleavage of highly cationic antimicrobial peptides by OmpT has been reported 
before (26), the ability of the engineered OmpT variants reported here, to cleave more 
complex folded antimicrobials like defensins was explored. Not surprisingly, the two 
mutants that had recognition sites in human-β -defensin3, eTR2 and eRV6, when 
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overexpressed in cells showed a greater than 2000 fold increase in viability compared to 
cells expressing no enzyme. A particularly interesting aspect of this result is that β-
defensins are believed to have evolved to resist proeteolysis (27) and yet overexpression 
of variants of the surface-displayed protease undermines its efficacy. 
 
3.5 Conclusions 
The ability to systematically modify the sequence specificity of OmpT to recognize 
unrelated, non-preferred sequences through the construction of large mutagenic libraries 
and high-throughput flow-cytometric screening has been demonstrated (Table 3.12). The 
activity of these engineered enzymes with their preferred substrates was as good (an in 
certain cases better) as OmpT with its preferred dibasic substrate. An examination of the 
overall specificity of these engineered OmpT variants demonstrated that high overall 
activity with the selection substrates was not achieved at the cost of overall specificity. 
This represents one of the first examples of engineered enzymes that posses both high 
overall activity and specificity (See Table 1.1 Chapter 1 and Table 3.12). The ability to 
engineer high activity with novel substrates, for which the starting parent has no activity, 
is particularly rare (35) (See also Table 1.1 Chapter 1 and Table 3.12). 
The systematic protease engineering shown here opens up other questions that can be 
answered fairly easily. For example, is it possible to recombine variants that recognize 
altered P1 amino acids with variants that recognize altered P1’ amino acids either through 
site-directed mutagenesis or using DNA shuffling and subsequent screening to create 
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chimeric enzymes that recognize a hybrid substrate sequence? Is it possible to counter-
select against multiple sequences and still isolate highly active enzymes? These questions 
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A1. StER3-ER-FRET Kinetic data 
































A3. Dot-plot of the Sat7 library labeled with 20 nM Thr↓Arg and 100 nM Arg↓Arg 
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